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Identification of Effectors of Synergistic Lethality in Candida albicansStaphylococcus aureus Polymicrobial Intra-abdominal Infection
Abstract
Candida albicans, an opportunistic fungal pathogen, and Staphylococcus aureus, a ubiquitous pathogenic
bacterium, are among the most prevalent causes of nosocomial infections and cause severe morbidity
and mortality. Moreover, they are frequently coisolated from central venous catheters and deep-seated
infections, including intra-abdominal sepsis. Relatively little is known about the complex interactions and
signaling events that occur between microbes and even less so how microbial “cross-talk” shapes human
health and disease.
Using a murine model of polymicrobial intra-abdominal infection (IAI), we have previously shown that
coinfection with C. albicans and S. aureus leads to synergistic lethality whereas monomicrobial infection
is nonlethal. Therefore, we aimed to identify staphylococcal virulence determinants that drive lethal
synergism in polymicrobial IAI. Using the toxigenic S. aureus strain JE2, we observed that co-infection
with C. albicans led to a striking 80-100% mortality rate within 20 h p.i while monomicrobial infections
were non-lethal. Use of a GFP-P3 promoter S. aureus reporter strain revealed enhanced activation of the
staphylococcal agr quorum sensing system during in vitro polymicrobial versus monomicrobial growth.
Analyses by qPCR, Western blot, and toxin functional assays confirmed enhanced agr-associated gene
transcription and increases in secreted α- and δ-toxins. C. albicans-mediated elevated toxin production
and hemolytic activity was determined to be agrA-dependent and genetic knockout and complementation
of hla identified ⍺-toxin as the key staphylococcal virulence factor driving lethal synergism. Analysis of
mono- and polymicrobial infection 8 h p.i. demonstrated equivalent bacterial burden in the peritoneal
cavity, but significantly elevated levels of α-toxin (3-fold) and the eicosanoid PGE2 (4-fold) during coinfection. Importantly, prophylactic passive vaccination using the monoclonal anti-⍺-toxin antibody
MEDI4893* led to significantly improved survival rates as compared to treatment with isotype control
antibody. Collectively, these results define α-toxin as an essential virulence determinant during C.
albicans-S. aureus IAI and describe a novel mechanism by which a human pathogenic fungus can
augment the virulence of a highly pathogenic bacterium in vivo.
We next sought to unravel the mechanism by which C. albicans drives enhanced staphylococcal ⍺-toxin
production. Using a combination of functional and genetic approaches, we determined that an intact agr
quorum sensing regulon is necessary for enhanced ⍺-toxin production during coculture and that a
secreted candidal factor likely is not implicated in elevating agr activation. As the agr system is pH
sensitive, we observed that C. albicans raises the pH during polymicrobial growth and that this correlates
with increased agr activity and ⍺-toxin production. By using a C. albicans mutant deficient in alkalinization
(stp2Δ/Δ), we confirmed that modulation of the extracellular pH by C. albicans can drive agr expression
and toxin production. Additionally, the use of various Candida species (C. glabrata, C. dubliniensis, C.
tropicalis, C. parapsilosis, and C. krusei) demonstrated that those capable of raising the extracellular pH
correlated with elevated agr activity and ⍺-toxin production during coculture. Overall, we demonstrated
that alkalinization of the extracellular pH by the Candida species leads to sustained activation of the
staphylococcal agr system.
Finally, we correlated ⍺-toxin production with significant increases in biomarkers of liver and kidney
damage during coinfection and determined that functional toxin was required for morbidity and mortality.
We next sought to determine the candidal effector(s) mediating this enhanced virulence by employing an
unbiased screening approach. C. albicans transcription factor mutants were evaluated for their ability to
induce S. aureus agr activation in polymicrobial culture. Incredibly, we identified several mutants that
displayed defects in augmenting S. aureus agr activity in vitro. Two of the mutants failed to completely
synergize with S. aureus in vivo and further analysis revealed the necessity of the uncharacterized C.

albicans transcription factor, ZCF13, in driving enhanced toxin production both in vitro and in vivo.
Collectively, we identified a novel effector by which C. albicans augments S. aureus virulence and
identified a potential mechanism of fungal-bacterial lethal synergism.
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ABSTRACT

Candida albicans, an opportunistic fungal pathogen, and Staphylococcus aureus,
a ubiquitous pathogenic bacterium, are among the most prevalent causes of nosocomial
infections and cause severe morbidity and mortality. Moreover, they are frequently
coisolated from central venous catheters and deep-seated infections, including intraabdominal sepsis. Relatively little is known about the complex interactions and signaling
events that occur between microbes and even less so how microbial “cross-talk” shapes
human health and disease.
Using a murine model of polymicrobial intra-abdominal infection (IAI), we have
previously shown that coinfection with C. albicans and S. aureus leads to synergistic
lethality whereas monomicrobial infection is nonlethal. Therefore, we aimed to identify
staphylococcal virulence determinants that drive lethal synergism in polymicrobial IAI.
Using the toxigenic S. aureus strain JE2, we observed that co-infection with C. albicans
led to a striking 80-100% mortality rate within 20 h p.i. while monomicrobial infections
were non-lethal. Use of a GFP-P3 promoter S. aureus reporter strain revealed enhanced
activation of the staphylococcal agr quorum sensing system during in vitro polymicrobial
versus monomicrobial growth. Analyses by qPCR, Western blot, and toxin functional
assays confirmed enhanced agr-associated gene transcription and increases in secreted αand δ-toxins. C. albicans-mediated elevated toxin production and hemolytic activity was
determined to be agrA-dependent and genetic knockout and complementation of hla
identified ⍺-toxin as the key staphylococcal virulence factor driving lethal synergism.
Analysis of mono- and polymicrobial infection 8 h p.i. demonstrated equivalent bacterial
burden in the peritoneal cavity, but significantly elevated levels of α-toxin (3-fold) and
the eicosanoid PGE2 (4-fold) during co-infection. Importantly, prophylactic passive
vaccination using the monoclonal anti-⍺-toxin antibody MEDI4893* led to significantly
improved survival rates as compared to treatment with isotype control antibody.
Collectively, these results define α-toxin as an essential virulence determinant during C.
albicans-S. aureus IAI and describe a novel mechanism by which a human pathogenic
fungus can augment the virulence of a highly pathogenic bacterium in vivo.
We next sought to unravel the mechanism by which C. albicans drives enhanced
staphylococcal ⍺-toxin production. Using a combination of functional and genetic
approaches, we determined that an intact agr quorum sensing regulon is necessary for
enhanced ⍺-toxin production during coculture but that a secreted candidal factor likely is
not implicated in elevating agr activation. As the agr system is pH sensitive, we observed
that C. albicans raises the pH during polymicrobial growth and that this correlates with
increased agr activity and ⍺-toxin production. By using a C. albicans mutant deficient in
alkalinization (stp2Δ/Δ), we confirmed that modulation of the extracellular pH by C.
albicans can drive agr expression and toxin production. Additionally, the use of various
Candida species (C. glabrata, C. dubliniensis, C. tropicalis, C. parapsilosis, and C.
krusei) demonstrated that those capable of raising the extracellular pH correlated with
elevated agr activity and ⍺-toxin production during coculture. Overall, we demonstrated
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that alkalinization of the extracellular pH by the Candida species leads to sustained
activation of the staphylococcal agr system.
Finally, we correlated ⍺-toxin production with significant increases in biomarkers
of liver and kidney damage during coinfection and determined that functional toxin is
required for morbidity and mortality. We next sought to determine the candidal
effector(s) mediating this enhanced virulence by employing an unbiased screening
approach. C. albicans transcription factor mutants were evaluated for their ability to
induce S. aureus agr activation in polymicrobial culture. Incredibly, we identified several
mutants that displayed defects in augmenting S. aureus agr activity in vitro. Two of the
mutants failed to completely synergize with S. aureus in vivo and further analysis
revealed the necessity of the uncharacterized C. albicans transcription factor, ZCF13, in
driving enhanced toxin production both in vitro and in vivo. Collectively, we identified a
novel effector by which C. albicans augments S. aureus virulence and identified a
potential mechanism of fungal-bacterial lethal synergism.
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CHAPTER 1. CANDIDA ALBICANS AND STAPHYLOCOCCUS AUREUS
PATHOGENECITY AND POLYMICROBIAL INTERACTIONS: LESSONS
BEYOND KOCH’S POSTULATES*
Challenging Koch’s Postulates: Polymicrobial Interactions
In 1890, Robert Koch published one of the seminal ideologies of modern
microbial pathogenesis, now commonly referred to as “Koch’s Postulates”. In order to
demonstrate causation between microbe and disease, four straightforward principles were
proposed: 1) the microbe must be found in all cases of the disease, but not in healthy
organisms, 2) the microbe must be isolated from the diseased individual and grown in
pure culture, 3) the isolated organism must cause disease in a healthy individual, and 4)
the microbe must be reisolated and reidentified as the original causative agent (1).
Despite the frequent violation of postulate 1, where healthy individuals often
asymptomatically carry opportunistic microbes, Koch’s postulates have largely led to a
global understanding of disease pathogenesis through the prism of a monomicrobial
infection model. However, we now know that microbes rarely exist as single species but
are often part of complex polymicrobial communities consisting of bacteria, fungi,
viruses, and protozoans. Therefore, it is logical to hypothesize that, at times, interactions
between these various microbes and the resulting modulation of gene and protein
expression profiles drive disease onset and outcome. Thus, it is difficult to satisfy
postulates 2 and 3, given that the existence of multiple microbes may be required to elicit
similar infectious outcome. Moreover, the complex interplay between host immune status
and genetic composition may confer susceptibility to one individual but not recapitulation
of the disease in a second (violation of postulates 3 and 4). While Koch’s Postulates have
served the field of microbiology very well in its early stages, their utility in helping to
understand the pathogenesis of polymicrobial infections is limited. Herein, we describe
various interactions employed by polymicrobial communities and focus on the fungal
pathogen Candida albicans and the bacterium Staphylococcus aureus as prototypical
organisms in understanding mechanisms driving exacerbated outcomes during coinfection.

Interkingdom Interactions and Polymicrobial Biofilms
Bacteria and fungi often occupy the same ecological and biological niches,
existing and interacting in various ways to persist, propagate, and prosper. While
microbes certainly exist as free-living forms, a majority of microbial life exists as sessile
communities coined “biofilms”. Biofilms are three-dimensional, structurally complex
___________
*Modified from final submission with open access permission. Todd, O.A.; Peters,
B.M. Candida albicans and Staphylococcus aureus Pathogenicity and Polymicrobial
Interactions: Lessons beyond Koch’s Postulates. J. Fungi 2019, 5, 81.(2)
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communities of one or more microbe, encased in an extracellular matrix consisting
largely of polysaccharides (3). These structures can be formed on both biotic or abiotic
surfaces and promote microbial consortia development. Biofilms allow for enhanced
adhesion to body surfaces, protection from environmental stressors and the host immune
system, and often result in increased tolerance to antimicrobial agents. Due to these
properties, biofilms are important sources of infection, and the capacity to form a biofilm
is considered an important virulence determinant.
With the advent of high-throughput genome sequencing, our knowledge regarding
the distinctive biodiversity existing at specific body sites has expanded exponentially. For
example, the oral cavity harbors over 700 unique species, the skin is home to
approximately 1000 species, and the gut maintains an incredible biomass composed of
greater than 1000 species (4, 5). Given the constrained biological space these organisms
share, physical, metabolic, secreted, and environmental mechanisms are bound to shape
their interaction. There are five general types of interactions observed within ecological
relationships: competition, predation, commensalism, parasitism, and mutualism (6).
These categories can be further simplified by delineating whether the interaction is
symbiotic or antagonistic.
Symbiotic relationships can be mutually beneficial for both microbes, favor one
microbe, or simply result in a neutral relationship. As mentioned above, the oral cavity is
a dynamic environment that plays host to numerous biofilm communities that can be
formed on both the mucosa and the tooth surfaces. While a number of different bacterial
species can be found in the mouth, Candida species are the dominant fungus of the oral
mycobiome (7). Candida spp. interact with Porphyromonas gingivalis, a Gram-negative
anaerobic bacterium that is commonly associated with the progression of periodontal
disease (8). Bartnicka et al. described the role of C. albicans biofilms in establishing an
anoxic environment in which P. gingivalis can robustly proliferate under such anaerobic
conditions, presumably driving gingival inflammation (9). Similarly, C. albicans also
demonstrates a mutualistic relationship with Streptococcus mutans—a common causative
agent of dental caries. S. mutans readily metabolizes dietary sucrose into glucose, which
is further rapidly metabolized by C. albicans, generating a persistent acidogenic-aciduric
microenvironment that promotes synergistic tooth demineralization and caries formation
(10-13).
In a competitive relationship, organisms compete for nutrients and resources
within a shared environment. An example of this kind of antagonistic relationship is seen
between Pseudomonas aeruginosa, a Gram-negative bacterium, and Rhizopus
microsporus, an environmental fungus responsible for a majority of mucormycosis cases.
Kousser et al. showed that these two microbes compete for iron within wounds;
specifically, P. aeruginosa secretes siderophores to take up iron, resulting in inhibition of
R. microsporus growth and germination (14). Although mediated through a different
mechanism, P. aeruginosa also displays antagonism against C. albicans by binding to the
fungus and secreting toxic phenazine compounds and homoserine lactones that are
capable of killing the fungus and repressing filamentation, respectively (15, 16). Multifaceted relationships (such as those described above) likely frequently occur but on a
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much grander scale, given the complexity of consortia on environmental and host
surfaces. These interactions undoubtedly shape microbial physiology with significant
consequences for both the microbe and host.

Getting the Lines Crossed: Quorum Sensing and Intermicrobial Communication
Interkingdom cross-talk is another component of the interactions between
communities of bacteria and fungi, which is mediated through recognition of signals as
part of quorum sensing (QS). QS is a density-dependent communicative signaling system
that regulates coordinated gene expression within a population (17). The discovery of QS,
first in bacteria and later in lower eukaryotes, such as fungi, reformed the idea that
microbes act independently, even when in a community, and are actually quite social
(17). QS is evolutionarily useful for microbes by sensing the changing environment and
adapting for the good of the community, including aiding in the acquisition and the
sharing of nutrients, tolerance to stress and antimicrobials, adaptation to ecological
niches, as well as enhancement of virulence in response to other microbial or host
organisms. In bacteria, the QS system relies on an accumulated signal molecule that is
produced and recognized by cells, and it is only at certain concentrations of this signal
that gene expression is modulated. Many of the signaling molecules are unique to specific
species and sometimes even to certain clades within species. For example, there exist
four divergent agr (accessory gene regulator) quorum sensing systems in Staphylococcus
aureus that produce different signaling molecules (AIP-I, II, III, and IV). These signals,
although structurally very similar, exhibit cross-inhibition, or interference, to the other
agr types. This agr interference leads to inhibition of transcription of the agr locus of
another type, perhaps providing a competitive advantage for the dominant strain (18).
Conversely, there is some evidence of degenerate signals and promiscuous receptors,
allowing for interspecies cross-talk (19). One study looked at the selectivity of QS
receptors across a number of bacterial species and discovered a range of recognition of
receptors to non-native quorum signals. Quantitative scoring of interactions took into
account the sensitivity of the receptor to the signal as well as the degree of activation
upon recognition. The RhlR QS receptor in P. aeruginosa is extremely selective for its
own quorum signal and showed the highest score in these experiments. On the other side
of the spectrum, the Btar2 receptor of Burkholderia thailandensis responded strongly to
several different QS signal molecules, including those from P. aeruginosa and Vibrio
fischeri. Based on these observations, the Btar2 receptor was defined as promiscuous
(19). In addition to bacteria, fungi also undergo QS (20). A large body of research exists
focusing on the C. albicans QS molecule farnesol, a byproduct of sterol synthesis that
represses filamentation without disrupting growth rate (21, 22). Interestingly, farnesol
also impacts susceptibility to antimicrobials or cell signaling against several bacterial
species, including S. aureus and P. aeruginosa (23-26). At high concentrations, farnesol
prevents S. aureus biofilm formation partially by damaging the bacterial membrane, and
it dose-dependently inhibits production of the carotenoid pigment staphyloxanthin,
conferring paradoxical resistance to oxidative stressors by increasing biosynthesis of antioxidant enzymes (27, 28). While quorum sensing systems exist in other fungal species,
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the specific molecules have not been identified but appear to be linked to control of
dimorphism (29).
The most well-described and studied bacterial QS system in S. aureus is the
accessory gene regulatory (agr) system (17, 30-32) (Figure 1-1). It consists of two
divergent promoters, P2 and P3, that drive expression of two separate transcripts, RNAII
and RNAIII, respectively. RNAII encodes for four genes, agrA, agrB, agrC, and agrD.
AgrA and AgrC make up a two-component system where AgrA is the response regulator
that, when phosphorylated by the membrane-bound histidine kinase AgrC, activates the
P2 promoter. AgrD is the pre-signal peptide that is modified and secreted through the
membrane-bound AgrB as the mature autoinducing peptide 2 (AIP-2). AIP-2 is then
recognized by AgrC, completing the signaling circuit. Alternatively, AgrA can also
activate the P3 promoter, driving expression of RNAIII—the effector of the quorum
sensing system. RNAIII directly encodes for δ-toxin at its 5’ end. The 3’ end contains a
consensus sequence that is complementary to the 5’ end of a number of staphylococcal
adhesin genes and, when in complex with such transcripts, prevents their translation by
masking the Shine-Dalgarno ribosomal binding site. Via this same mechanism, RNAIII
also inhibits the translation of the repressor of toxin (rot) transcriptional regulator,
allowing for increased production of toxins. Thus, QS signals (such as those produced by
agr system) are imperative in facilitating information exchange between microbial self
and non-self.

Candida albicans and Staphylococcus aureus: Co-Conspirators
C. albicans is a polymorphic fungus that exists as an opportunistic pathogen,
colonizing the gut and the mucosa of humans, and is one of the most prevalent human
fungal pathogens (33). The capacity to transition between yeast and invasive hyphal
morphologies is considered to be its key virulence attribute. The shift from commensal to
pathogen is usually due to changes in the immune status of the host. C. albicans can
cause superficial infections (e.g., candidiasis) of mucosal sites such as the mouth and the
vagina (34). Oral and vaginal candidiasis are the result of an overgrowth of the yeast and
are associated with robust inflammation of the mucosal surface (34, 35). A more serious
infection is candidemia, a systemic infection where Candida invades local tissue,
accesses the vasculature, and disseminates throughout the body via the bloodstream.
S. aureus is a Gram-positive coccus bacterium that can cause a variety of different
diseases ranging from skin and soft-tissue infections to severe bacteremia and sepsis (36).
The pathogenicity of S. aureus is primarily mediated through toxin production, which is
intimately linked to its quorum sensing system, described in detail above. S. aureus
produces a number of toxins: the membrane-damaging and cytolytic toxins ⍺- and δtoxin, Panton–Valentine leukocidin (PVL), and phenol-soluble modulins (PSMs) and the
superantigen toxic shock syndrome toxin (TSST), among numerous others (37). Aside
from damage-inducing toxin production, S. aureus can also perturb hemostasis through
manipulation of the clotting cascade, resist high levels of antimicrobials due to robust
biofilm formation, and avoid clearance by immune cells through capsular polysaccharide

4

Figure 1-1. Schematic of the agr quorum sensing system in Staphylococcus aureus.
AgrA is the response regulator in a two-component system that acts as a transcription
factor, modulating toxin production. (1) AgrA activates transcription from the P2
promoter, driving expression of RNAII, an operon consisting of four agr genes. AgrB is a
membrane-bound permease that processes AgrD, a pre-signal peptide, and releases it as
AIP-2 (auto-inducing peptide 2). AIP-2 is sensed by AgrC, a membrane-bound histidine
kinase that is part of the two-component signaling system. AgrC phosphorylates AgrA,
activating it, leading to a positive feedback loop. (2) Activated AgrA also drives
transcription from the P3 promoter, driving expression of RNA III, the effector of the QS
system. RNA III directly encodes for δ-toxin (hld) and also binds to repressor of toxin
(rot) transcript, allowing for toxin production by inhibiting rot translation. RNAIII also
binds to a number of adhesin-related genes to similarly block their translation.
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production (38-40). The multi-faceted and redundant nature of S. aureus virulence makes
it one of the most formidable human pathogens.
While C. albicans and S. aureus cause significant morbidity and mortality
independently, these microbes are also commonly found together at various body sites
and are implicated in a variety of diseases, including cystic fibrosis, ventilator-associated
pneumonia, urinary tract infections, superinfection of burn wounds, denture stomatitis,
and keratitis (41-44). Within the past decade, several in vitro and in vivo animal models
have revealed interesting clues as to how these pathogens may cooperate within the host
to exacerbate pathogenicity and disease.

Fungal-Bacterial Biofilms and Altered Drug Tolerance
Polymicrobial infections with C. albicans and S. aureus are common, due in part
to shared niches within the body, including co-isolation from skin, axillae, vagina,
pharynx, nasal passages, and oral mucosa (45). C. albicans and S. aureus both have the
ability to form biofilms and thus are commonly found growing in polymicrobial biofilms
on indwelling medical devices, such as catheters (Figure 1-2). These biofilms are
difficult to treat with antimicrobials, as the complex structure of the biofilm protects the
organisms by impeding drug permeability and immune cell access. Unfortunately,
treatment often involves replacing the catheter, which can be life-threatening in patients
with limited options for catheter reinsertion.
Among the earliest work to investigate the development of polymicrobial biofilms
by these species revealed that large staphylococcal aggregates formed around hyphal
filaments of C. albicans, and that S. aureus preferentially favored binding to these hyphal
filaments as compared to round yeast cells (46, 47) (Figure 1-3). Work by Harriott and
Noverr demonstrated that S. aureus displayed tremendous tolerance to vancomycin [over
1000-fold higher than the planktonic minimal inhibitory concentration (MIC)] during
biofilm growth with C. albicans. Follow-up studies revealed that viable C. albicans was
required for this phenotype, and that S. aureus became coated with dense extracellular
material during polymicrobial growth (46). Coating of S. aureus with isolated fungal
matrix polysaccharides (as evidenced by increased concanavalin A staining) revealed that
elevated antimicrobial tolerance was driven by encasement of bacteria by the dense
fungal extracellular meshwork. Additional studies revealed that C. albicans mutants (e.g.,
efg1Δ/Δ/cph1Δ/Δ) unable to adhere to the substratrum due to hyphal growth defects were
unable to augment vancomycin tolerance in S. aureus (48). Global or specific genetic
deletion of adhesins did not seemingly impact vancomycin tolerance profiles during coculture. Newer work by Kong et al. using both genetic and enzymatic approaches to
modulate matrix components coupled with fluorescence microscopy-based drug diffusion
assays identified the fungal polysaccharide β-1,3-glucan as the key moiety impeding
vancomycin penetration of the biofilm structure (49). This phenomenon of enhanced
staphylococcal drug tolerance during polymicrobial biofilm formation is not vancomycinspecific, as reduced susceptibility to doxycycline, nafcillin, and oxacillin has also been
observed (49). Moreover, the fungal quorum sensing molecule farnesol referred to above
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Figure 1-2. In vitro polymicrobial biofilm formation by C. albicans and S. aureus.
The image demonstrates S. aureus (green/merged, white arrows) attached throughout the
biofilm and along the hyphal filaments of C. albicans (blue). The extracellular matrix
(red) largely encases a majority of the staphylococci. Methods: A polymicrobial biofilm
was formed in vitro in RPMI-1640 medium with C. albicans (strain SC5314) and S.
aureus (strain M2) using 1x106 CFU of each microbe to inoculate a Permanox chamber
slide for 24 h at 37°C. Biofilms were washed with sterile saline to remove non-adherent
cells, fixed in 4% formalin, and stained with a cocktail containing calcofluor white (50
µg/mL), Concanavalin A-Texas Red (50 µg/mL), and Syto9 (1.67 µM). Images were
captured using 405 nm, 488 nm, and 565 nm lasers and DAPI, FITC, and Texas Red filter
sets with a Zeis 510 confocal scanning laser microscope. Corresponding Z-stacks were
constructed using packaged Zeis software depicting a side view. Scale bar represents 20
µm.
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Figure 1-3. Schematic of C. albicans-S. aureus interactions.
(1) S. aureus preferentially attaches to the hyphal filaments of C. albicans via binding of
the candidal adhesin Als3p. (2) Encasement of S. aureus in fungal biofilm matrix
components (including β-1,3-glucan) impairs penetration of antibiotics (purple triangle)
by sequestration of drug. The C. albicans QS molecule farnesol also upregulates drug
efflux pumps in S. aureus to enhance tolerance to antibacterials. (3) S. aureus is able to
gain access into subepithelial spaces by “hitchhiking” onto the invasive C. albicans
hyphae. S. aureus may also then disseminate to distant sites (including the kidneys)
following co-invasion via the bloodstream.
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was shown to activate staphylococcal drug efflux pumps, enhancing recalcitrance to
several antibacterial drugs (49). Thus, it is clear that co-culture of these organisms can
drastically alter phenotypic outcome with respect to drug tolerance and biofilm
architecture (Figure 1-3).

Enhanced Pathogenicity in the Oral Cavity and at a Distance
A major virulence factor of C. albicans is the ability to switch from yeast to
hyphae. The yeast form is suited for dissemination and initial seeding during infections,
while the hyphal form is crucial for tissue penetration and immune evasion and is
associated with upregulation of other virulence factors. One of these virulence factors is
the production of surface adhesins. Peters et al. demonstrated that S. aureus binds to C.
albicans hyphae through interaction with the candidal adhesin Als3p (50). Confocal
fluorescence microscopy of C. albicans–S. aureus biofilms qualitatively showed
decreased association of S. aureus to C. albicans hyphae lacking Als3p as compared to
wild-type. The strength of this interaction was quantified by measuring the adhesion
forces between C. albicans and S. aureus by atomic force microscopy, confirming
weaker binding when Als3p was genetically deleted (50). The importance of Als3p
binding by S. aureus during infection was demonstrated in an oral model of
polymicrobial infection (51). When the oral cavity was infected with C. albicans and S.
aureus, immunocompromised mice developed systemic infections with high microbial
burdens in the kidneys and elevated mortality. Mono-infected mice (C. albicans or S.
aureus alone) as well as mice infected with S. aureus and C. albicans als3/ did not
develop systemic infection (51). Similar results were found when S. aureus was coinoculated with the hypha-defective efg1Δ/Δ/ cph1Δ/Δ mutant of C. albicans (52). Thus,
both hyphae and Als3p are required for S. aureus to disseminate from the oral cavity. The
staphylococcal receptors required for robust binding to Als3p are likely multifactorial,
although S. aureus mutants defective for fibronectin binding protein B (Δfnb),
staphylococcal surface protein F (ΔsasF), and autolysin (Δatl) demonstrated reduced
capacity to bind hyphae in vitro (51). Cumulatively, these results led to development of a
hypothetical model in which S. aureus could “hitchhike” onto the invasive filaments of
C. albicans, gain access to submucosal tissue, and disseminate to distant sites
(Figure 1-3). Fluorescence in-situ hybridization images of tongue tissue from co-infected
mice supported this hypothesis, as hyphae embedded deep into the epithelium were found
surrounded by attached staphylococci (51).
C. albicans and S. aureus are both implicated in denture stomatitis, where the oral
mucosa is inflamed and lesions are formed (37). A study by Baena-Monroy et al.
examined saliva and culture swabs of denture surfaces from over 100 subjects fitted with
dentures (53). Using culture-based techniques, they found that C. albicans and S. aureus
could be recovered from the oral mucosa and the denture surfaces of both denture
stomatitis patients and healthy controls. However, increased levels of C. albicans was
recovered from the denture surface, while S. aureus was found predominantly in the oral
mucosa of denture stomatitis cases. These results suggest that C. albicans may facilitate
colonization of S. aureus during denture stomatitis and enable staphylococcal
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superinfection via a mechanism that could be explained by the aforementioned coinvasion hypothesis.

Polymicrobial Intra-Abdominal Infection and Lethal Synergism
Intra-abdominal infections (IAI) are a collection of a spectrum of diseases
characterized by microbial infection within the abdominal cavity and resulting
inflammation of the peritoneum. The majority of these infections are caused by a breach
of the gastrointestinal tract epithelium, facilitating the invasion of microbes (54). IAI are
the second most common cause of sepsis in intensive care unit (ICU) patients and
typically have a high mortality rate (55). Polymicrobial IAI are correlated with a more
severe disease state and higher rate of mortality, specifically when a fungal pathogen is
involved, with mortality reaching 80% (56). This is in contrast to IAI caused by bacteria
only, which display associated mortality rates of up to 30% (57). C. albicans and S.
aureus are among the top most commonly isolated organisms during IAI (56).
Dissemination of microbes from the peritoneal cavity leads to systemic infection and can
progress to sepsis. Sepsis is caused by the dysregulation of the immune system in
response to infection (often hyper-inflammatory, followed by anergy) and is associated
with severe organ damage and failure with a rapid onset of mortality (58).
Early studies conducted by Carlson described a synergistic effect on mortality in a
mouse model of C. albicans–S. aureus polymicrobial IAI (59). The LD50 of the C.
albicans strain was 2.9 × 108 CFU (colony-forming unit); the LD50 of the S. aureus strain
(2460, isolated from a patient with toxic shock syndrome) was determined to be 8 × 108
CFU. Outbred CD-1 mice were infected intraperitoneally (i.p.) with C. albicans (7 × 106
CFU), S. aureus (8 x 107 CFU), or C. albicans + S. aureus at these same doses in saline.
Results indicated that monomicrobial infection of either C. albicans or S. aureus was
nonlethal, whereas dual infection with these sub-lethal doses of each organism caused
nearly 100% mortality within three days post infection (d p.i.). Further experiments
indicated that the ideal ratio of S. aureus:C. albicans to display synergistic lethality was
approximately 10:1. Additionally, heat-inactivation of either organism eliminated this
apparent synergism (59). These experiments helped develop initial concepts of
synergistic lethality, whereby two microbes interact in a way that augments the virulence
of one or both organisms, leading to enhanced morbidity and/or mortality.
Subsequent studies by Carlson evaluated the interaction between C. albicans and
additional pathogenic bacteria, including Serratia marcesans and Enterococcus faecalis
(60). Interestingly, C. albicans was able to enhance virulence with all bacterial species
tested, again using sub-lethal doses of both fungi and bacteria. Analysis of the blood, the
pancreas, the kidney, and the spleen demonstrated that E. faecalis or S. marcesans
burdens were nearly identical in the respective tissues, regardless of the initial dose when
given along with a standard dose of C. albicans. It was also noted that the bacterial
burden in mice infected with bacteria alone was undetectable, whereas C. albicans
colonization was unaltered by the presence or the absence of bacteria. Thus, a major
conclusion from this work was that, although C. albicans amplifies the virulence of other
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microbes, this synergism does not seem to be mutual, as the bacteria tested did not appear
to affect the colonization or the virulence of C. albicans during polymicrobial IAI (60).
Carlson further defined the infectious relationship between C. albicans and S.
aureus in murine polymicrobial IAI. Robust synergistic lethality was only observed when
both pathogens were given i.p. (61). Interestingly, when C. albicans was given i.p. and S.
aureus was inoculated subcutaneously (s.c.), lethality was observed in 30% of animals,
and mixed infection was established only at the site of fungal inoculation. This suggests
that S. aureus is migratory during infection and that C. albicans is needed for
staphylococcal colonization to persist, perhaps due to some yet identified protective
effect provided by the fungi (61). Despite these important fundamental findings, the
mechanism of synergistic lethality between C. albicans and S. aureus in polymicrobial
intra-abdominal infection was left largely undefined until recently.

Mechanisms of Synergistic Lethality: A Role for Staphylococcal Toxins
Decades following the groundwork laid by Carlson, a new study emerged
providing insight into the pathogenesis of C. albicans–S. aureus IAI (62). Similar to
previous findings, intra-abdominal co-infection with C. albicans and S. aureus led to
synergistic lethality with mice succumbing to infection by approximately 48 h p.i.
Attention to the host response revealed significantly higher levels of neutrophils recruited
to the peritoneal cavity during co-infection along with synergistic increases in cytokines
Interleukin-6 (IL-6), Granulocyte-Colony Stimulating Factor (G-CSF), Keratinocyte
Chemoattractant (KC), Monocyte Chemoattractant Protein-1 (MCP-1), and Macrophage
Inflammatory Protein 1-⍺ (MIP-1) in the spleen and the kidneys, indicating robust
inflammation. Interestingly, this study also revealed synergistic increases of the
eicosanoid Prostaglandin E2 (PGE2) in the peritoneal lavage fluid. Prophylactic reduction
of PGE2 using the cyclooxygenase inhibitor indomethacin significantly protected mice
from co-infection and lowered inflammatory markers. Importantly, staphylococcal toxins,
including ⍺- and δ-toxin, have been shown to activate phospholipase A2 signaling,
leading to increased generation of prostaglandins (63, 64).
In order to unravel the mechanism of interaction between these two important
pathogens, one must consider the virulence determinants of both organisms as well as the
host response in driving the synergistic lethality. For C. albicans, this includes the
morphological switch from yeast to hyphae and adhesive factors. Interestingly, in
contrast to the oral co-infection model, Als3p binding was found to have no influence on
synergistic mortality during C. albicans–S. aureus polymicrobial intra-abdominal
infection (65). This finding was indirectly supported by Nash et al. in their investigation
into the role of morphogenesis during C. albicans–S. aureus polymicrobial infection.
This study showed that a yeast-locked C. albicans strain had no defect in promoting
lethal synergism with S. aureus during polymicrobial IAI as compared to co-infection
with a wild-type strain (66). Additionally, a hypha-“locked” C. albicans strain did not
show enhanced mortality as compared to wild-type infection (66). Moreover, co-infection
with a variety of non-albicans Candida species resulted in disparate infectious outcomes.
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Co-infection of S. aureus with Candida krusei (does not form hyphae) led to synergistic
mortality similar to that of co-infection with C. albicans, while co-infection with Candida
dubliniensis (close filamentous phylogenetic relative of C. albicans) was non-lethal (67).
These data indicate that the morphology of C. albicans is not required for its ability to
enhance S. aureus virulence during IAI. Interestingly, co-infection with the hyphadefective efg1Δ/Δ/cph1Δ/Δ mutant failed to drive lethal synergism, indicating that
expression of downstream target genes and not hyphal growth per se are important
factors promoting infectious synergism (68).
As mentioned prior, S. aureus virulence is mainly due to toxin production and is
intimately tied to QS. However, not all S. aureus strains have the same toxin profile, as
major inter-strain heterogeneity with respect to genetic presence/absence and relative
expression of toxin-producing genes is apparent (69, 70). Carlson used various S. aureus
strains with different toxin profiles in her initial studies of C. albicans–S. aureus
synergism, focusing on toxic-shock syndrome (TSS)-associated isolates and non-TSS
disease-associated isolates (71). Unsurprisingly, the majority of TSS-associated isolates
were positive for toxic shock syndrome toxin (TSST), while the non-TSS isolates were
negative. She found that polymicrobial infection in mice with C. albicans and TSSassociated S. aureus strains led to 100% mortality within 2 d p.i., whereas non-TSSassociated strains caused 100% mortality much sooner, typically within 15 h p.i. Due to
the lack of genetic tools and isogenic strains at the time, further characterization of
specific toxins was not possible, thus it is unknown which other toxin(s) played a role in
these results (71). Despite this, Carlson’s work using spent culture supernatants from S.
aureus during co-infection clearly hinted that staphylococcal exotoxins contribute to
synergistic lethality (72).

Lessons Learned, Yet Questions Remain
While we have gained significant insight into the complex relationship existing
between C. albicans and S. aureus, there is still much to learn regarding this fascinating
microbial pair. Therefore, the purpose of this work was to answer several of the many
remaining questions regarding the mechanism of synergistic lethality between C.
albicans and S. aureus: What are the specific factors, both fungal and bacterial, that
contribute to lethality? How does the host respond to polymicrobial infection, and is this
response a significant cause of morbidity and mortality? What exactly is driving lethality:
microbial growth and dissemination, organ damage, sepsis, hyperinflammatory
responses? How can we prevent, detect, and effectively treat these types of infections? As
sequencing technologies become less expensive and more sensitive, it will be imperative
to understand how microbiome, metagenome, and immune system shape these
interactions within the human host, so that optimal and targeted therapies can be devised.
Along with others, these case studies regarding C. albicans-S. aureus interactions have
allowed the microbiology field to peer beyond the monomicrobial paradigm that Koch
proposed a century before and have helped usher in a new frontier. If this much
information has been gleaned from a single fungal-bacterial pairing, exciting discoveries
on the horizon regarding additional microbial interactions are virtually endless.
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CHAPTER 2. CANDIDA ALBICANS AUGMENTS STAPHYLOCOCCUS
AUREUS VIRULENCE BY ENGAGING THE STAPHYLOCOCCAL AGR
QUORUM SENSING SYSTEM*

Introduction
The pathogenic fungus Candida albicans and ubiquitous bacterial pathogen
methicillin-resistant Staphylococcus aureus (MRSA) remain serious clinical threats (73,
74). Together, these microorganisms rank among the most prevalent causes of
nosocomial sepsis and catheter-related bloodstream infections, and recent reports have
identified their coisolation with increasing frequency (75, 76). While polymicrobial
infection is often associated with poor patient prognosis, studies designed to
mechanistically evaluate microbial community composition and fungal-bacterial
interactions in the context of host immunity are still in their infancy (77).
Comprehensive epidemiological data on S. aureus has identified several distinct
clades, each characterized by unique disease pathology and virulence factors. Among
these are USA200 and USA300 strains, which are commonly referred to as hospital
acquired (HA) or community acquired (CA) MRSA, respectively. Generally, HA-MRSA
strains are robust formers of staphylococcal biofilm and demonstrate wider antimicrobial
resistance profiles, and some clades (e.g. CC30) exhibit lower levels of secreted bacterial
toxins (78). These strains are often associated with orthopedic and medical device-related
infections. Conversely, CA-MRSA strains secrete comparatively higher levels of
bacterial toxin, including Panton-Valentine Leukocidin (PVL) and the pore-forming
cytolytic α-toxin (73). These strains have been associated with skin infection outbreaks
(e.g. in prisons, care facilities, locker rooms), and it is believed that high levels of toxin
and other secreted factors allow for efficient skin-skin and skin-fomite transfer. Toxin
expression in S. aureus has been linked with multiple bacterial sensory regulators, but
perhaps the best studied is the agr (accessory gene regulator) quorum sensing system
(79).
The agr system is the product of the RNAII transcript, consisting of an operon
composed of four genes (agrA,B,C,D) (79). AgrD is the signal peptide, which gets
secreted across the bacterial membrane into the extracellular space and modified to its
mature form, auto-inducing peptide 2 (AIP-2), via translocation through AgrB. AIP-2 is
sensed by the cell surface-associated AgrC receptor that induces phosphorylation of
AgrA. Activated AgrA can then bind again to the P2 promoter to increase RNAII
transcription, completing a positive feedback cycle that is increased in a cell-density
dependent fashion (i.e. quorum sensing). However, activated AgrA can also bind to the
___________
*Reprinted from final submission with open access permission. Todd OA, Fidel PL, Jr.,
Harro JM, Hilliard JJ, Tkaczyk C, Sellman BR, Noverr MC, Peters BM. 2019. Candida
albicans Augments Staphylococcus aureus Virulence by Engaging the Staphylococcal
agr Quorum Sensing System. mBio 10.(65).
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P3 promoter to drive expression of the RNAIII transcript, which directly encodes for δtoxin and a post-transcriptional regulatory RNA. Expression of RNAIII decreases
transcription of rot (repressor of toxin), thereby increasing exotoxin secretion (80). Both
α- and δ-toxin are well-characterized staphylococcal virulence factors, mediating a
variety of pathological effects, including hemolytic activity, dermonecrosis,
inflammasome activation, abscess formation, leukocyte oxidative burst, and reduced
macrophage phagocytic killing (81-85). Toxin production by S. aureus is crucial for
systemic disease, as high titers of antibody to staphylococcal exotoxins (including αtoxin) directly correlates with improved survival rates during clinical S. aureus sepsis
(86).
A series of studies by Carlson demonstrated that peritoneal coinoculation of mice
with C. albicans and S. aureus resulted in synergistic increases in mortality, while mice
inoculated with each of these microbes alone efficiently cleared the infection (59, 71, 72).
It was also observed that not all strains of S. aureus resulted in polymicrobial infectious
synergism equally, with some decreasing the staphylococcal LD50 by as much as 70,000fold while others demonstrated only modest synergistic effects (2-3 fold) (71). It was
proposed that expression of specific staphylococcal toxins governed increased mortality,
namely α-toxin and δ-toxin. Unfortunately, lack of isogenic controls complicated data
interpretation. Recently, our lab recapitulated these findings using a USA200 strain of S.
aureus (NRS383) and identified that the host eicosanoid prostaglandin E2 (PGE2) is
associated with disease severity and pharmacologic blockade of PGE2 synthesis and
PGE2 receptors 1 and 3 dramatically improves survival rate (62, 66, 87). Interestingly,
staphylococcal exotoxins have been implicated in activation of phospholipase A2 and
subsequent prostaglandin release (63, 88). Furthermore, synergistic effects on mortality
and PGE2 generation during coinfection with S. aureus are independent of the capacity to
undergo fungal morphogenesis (the major virulence attribute of C. albicans) and are not
limited to C. albicans, as various other Candida species (including C. dubliniensis, C.
tropicalis, and C. krusei) also enhance morbidity and mortality during intra-abdominal
infection (IAI) (66, 67).
Regarding the potential link to toxin expression and synergistic lethality with C.
albicans, the objective of this study was to identify whether staphylococcal toxins may be
required for lethal co-infection and/or whether toxin expression is elevated during
polymicrobial IAI. In support of this, we show strong in vitro and in vivo evidence that
staphylococcal α-toxin is necessary for robust infectious synergism and that C. albicans
augments staphylococcal toxin production via engagement of the agr quorum sensing
system.
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Materials and Methods

Ethics Statement
The animals used in this study were housed in AAALAC-approved facilities
located at the University of Tennessee Health Sciences Center (UTHSC) in the Regional
Biocontainment Laboratory. The UTHSC Animal Care and Use Committee, Laboratory
Animal Care Unit (LACU) approved all animal usage and protocols (protocol #18-060).
Mice were given standard rodent chow and water ad libitum. Mice were monitored daily
for signs of distress, including noticeable weight loss and lethargy. UTHSC LACU uses
the Public Health Policy on Humane Care and Use of Laboratory Animals (PHS) and the
Guide for the Care and Use of Laboratory Animals as a basis for establishing and
maintaining an institutional program for activities involving animals. To ensure high
standards for animal welfare, UTHSC LACU remains compliant with all applicable
provisions of the Animal Welfare Act (AWAR), guidance from the Office of Laboratory
Animal Welfare (OLAW), and the American Veterinary Medical Association Guidelines
on Euthanasia.

Strains and Growth Conditions
C. albicans strain SC5314 (wild-type, reference isolate) was used for all
experiments. The following S. aureus strains obtained from the Biodefense and Emerging
Infectious (BEI) Research Resources repository were used: JE2 (WT, USA300 derived
from strain LAC but cured of erythromycin resistance and cryptic plasmids), NE1532
(ΔagrA), and NE1354 (Δhla) (89). The S. aureus reporter strain harboring plasmid
pDB22 encoding for erythromycin resistance and a P3 promoter fused to GFPmut2 was a
kind gift from Dr. Pete Greenberg (University of Washington) (90). Using standard
techniques, plasmid pDB22 was isolated from MN8-pDB22 and transformed into strain
JE2 by electroporation to yield S. aureus(pDB22) (61). Using fluorescence microscopy, it
was confirmed that S. aureus(pDB22) exhibited robust GFP expression during stationary
growth, consistent with agr activation (Figure 2-1). All strains were maintained as 20%
glycerol stocks and stored at -80°C.
Unless specifically noted otherwise, C. albicans was streaked onto Yeast Peptone
Dextrose (YPD) agar. Isolated colonies were selected and inoculated into liquid YPD
medium and grown overnight at 30°C with shaking at 200 rpm. S. aureus was streaked
onto Trypticase Soy Agar (TSA) with antibiotic selection as required. Isolated colonies
were selected and inoculated into liquid Trypticase Soy Broth (TSB) medium and grown
overnight at 37°C with shaking at 200 rpm. The following day cultures were diluted
1:100 in fresh TSB and returned to the shaking 37°C incubator for 3 h until cultures
reached the logarithmic phase of growth.
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Figure 2-1. S. aureus(pDB22) demonstrates GFP expression in a cell density
dependent manner, consistent with predicted agr/P3 promoter activity.
Reporter plasmid pDB22 was isolated from S. aureus strain MN8 and transformed into
strain JE2 to yield strain S. aureus(pDB22). Specificity of GFP signal was assessed by
inoculating both strains into TSB-g, incubating at 37°C for 16 h, and imaging by
fluorescence microscopy using a DIC/GFP filter set.
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Construction of an hla-Complemented Strain
In order to complement ⍺-toxin expression, primers (restriction enzyme sites
indicated by underlined text) hlaF-HindIII (5’-GTAAAGCTTCATACGATACTTTTTC
GTTATCTATTAG) and hlaR-BamHI (5’-CGGGGATCCCAGTATAAAAATTAG
CCGAAAAACATCATTTCTG) were used to PCR amplify genomic DNA isolated from
strain JE2 to generate a fragment containing the entire hla open reading frame, ~500 bp
of the 5’ untranslated region (UTR), and ~100 bp 3’UTR. Vector pSK5630 (a low copy
plasmid, ~5 per cell) and the hla PCR product were digested with HindIII and BamHI
and ligated to yield plasmid pSK-hla. The dcm-deficient Escherichia coli strain IM08B
was made chemically competent and used as a propagation host for pSK-hla after
standard heat-shock transformation and selection on Luria-Bertani (LB) agar containing
ampicillin (50 μg/mL) to yield strain IM08B-phla (91). pSK-hla was isolated from
selective overnight cultures of IM08B-phla using a miniprep procedure according to
manufacturer’s protocol (GeneJet, ThermoFisher) and verified by restriction digest with
HindIII and BamHI, followed by Sanger sequencing (UTHSC, Molecular Resource
Center). Using a vendor optimized protocol for staphylococcal electroporation
(GenePulser Xcell, Bio-rad), pSK-hla was transformed directly into strain NE1354 (Δhla
background) and plated on Brain Heart Infusion agar containing chloramphenicol (10
μg/mL) to yield strain Δhla-phla. Individual colonies were replica plated onto TSA agar
containing 5% sheep’s blood and chloramphenicol (10 μg/mL) to screen for those with a
hemolytic phenotype. Plasmids were isolated from hemolysis-positive colonies by
miniprep procedure using a S. aureus-specific manufacturer-supplied protocol (Qiaprep,
Qiagen) and verified by PCR amplification using primers pSK5630-F (5’-ACGATGCG
ATTGGGATATATCAACG) and hlaDETR (5’-GTGTTGTTGTTACTGAGCTGACT
ATACG).

Murine Model of IAI
Intraperitoneal (i.p.) inoculations were conducted as described previously (62, 66,
67). In most experiments, groups (n = 4) of six-week old Swiss Webster mice were
injected i.p. using a 27-gauge ½” needle with 1.75 x 107 CFU of C. albicans, 8 x 107
CFU of S. aureus, or 1.75 x 107 and 8 x 107 CFU of the respective microbe
simultaneously. Inocula were prepared in a final volume of 0.2 mL pyrogen-free
phosphate-buffered saline (PBS). After inoculation, mice were observed up to 10 d p.i.
for morbidity (hunched posture, inactivity, ruffled fur) and mortality. Mice that exhibited
severe morbidity were humanely sacrificed and tallied as a lethal outcome. In some
experiments, mice were sacrificed 8 h p.i. prior to severe morbidity. Peritoneal cavities
were lavaged by injection of 2 mL of sterile PBS containing 1X protease inhibitors
(cOmplete, Roche) followed by gentle massaging of the peritoneal cavity. Peritoneal
lavage fluid was then removed using a pipette inserted into a small incision in the
abdominal cavity. Animal experiments were repeated in duplicate and results combined.
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Passive Immunization with an Anti-⍺-Toxin Monoclonal Antibody
Groups of mice (n = 4) were inoculated i.p. with 200 µl of the ⍺-toxin specific
IgG1 neutralizing antibody MEDI4893* (15 mg/kg, 45 mg/kg) or human IgG1 isotype
control R347 (45 mg/kg) prepared in sterile PBS 24 h prior to co-infection with C.
albicans and S. aureus. Mice were monitored for up to 10 d p.i. for morbidity and
mortality. Animal experiments were repeated in duplicate and results combined.
Intraperitoneal Delivery of ⍺-Toxin
Groups of mice (n = 4) were inoculated i.p. with 0.2, 0.5, 0.75, 1, or 5 μg of
purified native α-toxin in 0.1 mL of PBS alone or sequentially with 1.75 x 107 CFU of C.
albicans in 0.1 mL PBS (84). Mice inoculated with ⍺-toxin only received a sham
injection of 0.1 mL PBS. Mice were monitored for morbidity and mortality up to 10 d p.i.
Data is representative of at least 2 independent repeats.

CFU Analysis
Microbial burdens were enumerated by serial dilution plating of peritoneal lavage
fluid and culture media onto YPD containing 20 μg/mL ampicillin and 2 μg/mL
vancomycin (for C. albicans enumeration) and TSA containing 20 μg/mL ampicillin and
2.5 μg/mL amphotericin B (for S. aureus enumeration) via the drop-plate method (92).
Plates were incubated overnight at 37°C, and the microbial burden was enumerated and
expressed as CFU per mL. CFU values are representative of at least 2 independent
repeats (n = 4 mice per group) and represented as the median (± SD).

Prostaglandin Quantitation
Recovered lavage fluid was centrifuged at 500xg for 5 min, and the supernatant
was transferred to clean microfuge tubes. PGE2 is rapidly converted to its 13,14-dihydro15-keto metabolite in vivo, so the colorimetric Prostaglandin E Metabolite competitive
enzyme immunoassay (EIA) was used to measure PGE2 as a function of its breakdown
product, according to the manufacturer’s directions (Cayman Chemicals, Ann Arbor,
MI). This assay is highly sensitive and detects as little as 2 pg/mL of PGE metabolites.
S. aureus ⍺-Toxin Quantitation by ELISA
Wells of a polystyrene 96-well microtiter plate were coated with 50 μl of 0.1
μg/mL anti-α-toxin antibody MEDI4893* (diluted in coating buffer (0.2 M
carbonate/bicarbonate buffer)) and incubated overnight at 4°C. Plates were washed
sequentially with PBS-Tween 20 (PBS-T) and blocked with SuperBlock (Pierce) for 1 h
at room temperature. After washing with PBS-T, 50 μl of diluted peritoneal lavage fluid
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or diluted filter-sterilized culture supernatants in PBS was added. Additionally, serial
dilutions of native α-toxin were included as the standard curve. The plate was then
incubated for 1 h at room temperature with shaking (600 rpm). After washing with PBST, 50 μl of affinity-purified rabbit polyclonal anti-α-toxin antibody (2 μg/mL) was added
and incubated as described above. After washing, 50 μl of a 1:10,000 dilution of
Affinipure horseradish peroxidase (HRP)-coupled goat anti-rabbit IgG detection antibody
(Jackson Immuno Research) was added and incubated for 1 h. Plates were washed
extensively with PBS-T, and then 100 μl of 3,3’,5,5’-Tetramethylbenzidine (TMB)
substrate was added for 10 min, followed immediately by 100 μl of ELISA stop solution
(0.2 M H2SO4) was added. Wells were read at 450 nm using a plate reader (Synergy,
Biotek), and experimental values were extrapolated to the standard curve. Culture
supernatants and peritoneal lavage fluid generated from the Δhla strain were blank
subtracted to account for any potential nonspecific antibody binding to shed protein A.
Experiments were repeated in duplicate (n = 4 mice per group), and data were combined
and expressed as the mean ± SEM.

Agar Plate Assay for Toxin Activity
Colonies of S. aureus (JE2, ΔagrA, Δhla) and C. albicans were grown overnight
as described above, and cell densities adjusted to 1 x 107 CFU/mL by counting on a
hemocytometer. A 1:100 dilution (50 μl) was made into 5 mL of 0.6X TSB containing
0.2% glucose (TSB-g) (a medium previously shown to support good growth of both C.
albicans and S. aureus) to establish the following groups: S. aureus alone, C. albicans
alone, or C. albicans and S. aureus (93, 94). Monomicrobial cultures received an
additional 50 μl of sterile PBS. Tubes were placed in a 37°C incubator with shaking at
200 rpm. Aliquots were removed at several time points, centrifuged at 5000 rpm to
remove cellular debris, and passed through a 0.2 μm syringe filter. Wells were aseptically
formed in TSA agar blood containing 5% sheep’s blood using a cut sterile pipette tip.
Sterile culture supernatant (20 μl) was added to each well and the plate incubated at 37°C
for up to 24 h. Plates were imaged using a digital scanner and are representative of at
least 3 independent repeats.

RBC Hemolytic Assay
An aliquot (1 mL) of rabbit blood (Lampire Biologicals) was centrifuged at
1000xg for 5 min to pellet RBCs. Packed red cells were washed 2X further by
centrifugation, resuspended in 1 mL, and a 4% v/v dilution of RBCs made. Isolated cellfree supernatants (as described above) were serially diluted in sterile TSB-g and 200 μl
added to wells of a microtiter plate. To this, 50 μl of RBCs were added and plate
incubated at 37°C for 1 h with gentle shaking. Plates were centrifuged at 1000xg for 5
min to pellet unlysed RBCs, supernatants transferred to a fresh microtiter plate, and the
OD405 nm collected as measure of hemoglobin release. Positive (1% Triton-X 100) and
negative (sterile TSB-g) controls were included. Experiments were repeated in triplicate,
values normalized as % of positive control, and expressed as the mean ± SEM.
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agrA-GFP Reporter Assay
Culture setup was similar to the agar plate assay described above, except that the
S. aureus(pDB22) strain was also included and 10 μg/mL of erythromycin was included
for plasmid maintenance. Aliquots of cultures (100 μl) were removed at various time
points post-inoculation in TSB-g and placed into wells of a black microtiter plate in
triplicate. Fluorescence (488 nm excitation, 515 nm emission) was captured on a plate
reader (Synergy, Biotek). Experiments were repeated in triplicate, and results expressed
as mean arbitrary fluorescence units (AFUs) ± SEM.

Fluorescence Microscopy
Aliquots of cells from the reporter assay were stained with the fluorescent DNA
stain Syto62 as per manufacturers protocol (Invitrogen) and placed onto cover-slipped
glass slides. Images were captured on an Olympus FV1000 confocal microscope using
GFP and Texas Red filter sets. Samples of peritoneal lavage fluid were placed onto glass
slides and imaged using DIC and GFP filter sets. Images are representative of at least 3
independent repeats.

RNA Isolation for qPCR
Cultures were setup as described for the agar plate assay. RNA from S. aureus
was selectively isolated as described, with some modifications (95). Briefly, cells were
removed from the incubator and an equal volume of ice-cold 50% Acetone/50% ethanol
was added to prevent RNA degradation. Cells were centrifuged 2X at 4000 rpm and
resuspended in 1 mL of DEPC-treated water. Cells were transferred to eppendorf tubes,
centrifuged, and 5 μl of lysostaphin added (10 mg/mL). The pellet was vortexed
vigorously, resuspended in 200 μl of DEPC water, and incubated in a 37°C water bath for
45 min. To this, 2.5 μl of proteinase K (Qiagen) was added and incubated for an
additional 15 min. After incubation, 0.2 volumes of 10% SDS was added, followed by an
equal volume of pH 4 125:24:1 phenol:chloroform:isoamyl alcohol, and a small amount
of 0.1 mm zirconia beads. Tubes were vortexed vigorously for 2 min, followed by 1 min
incubation on ice; this was repeated 3X total. RNA was extracted by the hot
phenol:chloroform method (5:1, pH 4), precipitated with 3 M sodium acetate, and washed
with 70% ethanol. The pellet was air-dried and resuspended in 25 μl DEPC water.
Concentrations were assessed spectrophotometrically (A260/A280 ratio) and RNA integrity
verified by running ~ 1 μg of RNA on a 1.4% TBE agarose gel. Analysis of 16S and 23S
ribosomal (but lack of 18S and 28S) RNA bands confirmed that staphylococcal RNA
from polymicrobial cultures was selectively extracted using this procedure.
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qPCR for Staphylococcal Genes
Trace amounts of contaminating DNA were removed from RNA samples (1 μg)
by treatment with RNase-free DNase I per the manufacturer’s protocol (Thermo Fisher).
RNA was reverse transcribed using the Revertaid first-strand kit and primed with random
hexamers per the manufacturer’s protocol (Thermo Fisher). cDNA (100 ng) was
amplified using gene-specific primers (Sigma) and the Maxima Sybr Green 2X PCR
mastermix per the manufacturer’s protocol (Thermo Fisher). Amplification and
fluorescence measurement were conducted using the 7500 Real Time PCR System
platform (Applied Biosystems). Expression levels of target genes in polymicrobial
cultures were compared to those in monomicrobial cultures and normalized to
staphylococcal reference gene gyrB using the ΔΔCT method as described previously (96).
RNA was extracted from triplicate experiments, ΔΔCT values calculated, averaged, and
expressed as the mean ± SD.

Western Blotting for Staphylococcal Proteins
Cell-free supernatants were separated into ethanol-soluble and insoluble fractions
by treatment with 80% final v/v ice-cold ethanol for 1 h at -80°C. Samples were
centrifuged at 3000xg for 15 min. The ethanol-soluble fraction was transferred to a clean
tube and both fractions were placed in a N-EVAP nitrogen evaporator (Organomation)
set at 75°C and 10 mm flow. Upon reaching near-dryness, samples were resuspended in
0.5 mL of ultrapure water, and total protein content assessed by the bicinchoninic (BCA)
assay (Pierce). Equivalent volumes (40 μl) of concentrated supernatants were diluted in
6X Laemli sample buffer, boiled, and separated by SDS-PAGE in duplicate. We chose
not to normalize to total protein, as the polymicrobial culture would have elevated levels
of protein (both C. albicans and S. aureus) and may bias interpretation when compared to
monomicrobial cultures. Ethanol-soluble fractions were assessed using Tris-Tricine
electrophoresis and insoluble fractions using a Tris-Glycine system. Equivalent protein
load was confirmed by staining one set of gels with Biosafe-Coomassie, while the other
gel was transferred to nitrocellulose membranes and blocked in 5% powdered milk PBST for antibody probing as follows. To detect α-toxin, a 1:10,000 dilution of primary
rabbit anti-α-toxin (Sigma, S7531) and 1:50,000 dilution HRP-coupled anti-rabbit IgG
antibodies were used. To detect δ-toxin, 1:1,000 dilution of primary rabbit anti-δ-toxin
(LSBio, LS-C156026) and 1:50,000 dilution HRP-coupled anti-rabbit IgG antibodies
were used. To detect protein A, a 1:2,000 dilution of mouse anti-protein A (Abcam,
ab181627) and 1:50,000 of goat anti-mouse IgG (Fab specific) were used. Primary
antibodies were incubated overnight at 4°C in blocking buffer with gentle rocking.
Secondary antibodies were incubated for 1 h at room temperature with gentle rocking.
Gels were washed at least 3X for 5 min with PBS-T between incubation steps. Signal was
detected using the SuperSignal Chemiluminescent Substrate kit (Pierce) as per
manufacturer’s protocol and exposure images captured on the ChemiDoc XRS system
(Bio-rad). Densitometry of resulting bands was calculated using ImageJ software (NIH).
Blots are representative of 3 independent repeats.
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Statistical Analysis
A two-tailed Mann Whitney test was used to compare CFU values between
polymicrobial and monomicrobial groups. A two-tailed unpaired Student’s T-test was
used to compare AFU and RBC lysis values for polymicrobial vs. monomicrobial groups.
A Wilcoxon log-rank test was used to determine significance of mortality plotted in
Kaplan-Meier curves. Statistical analyses were performed using GraphPad Prism.
Significance is denoted as follows: *, P < 0.05; **, P < 0.01. All graphs were constructed
using GraphPad Prism. Figures were composed using MS Powerpoint and rendered for
publication with Adobe Photoshop.

Results

A USA300 Strain Exhibits Robust Synergistic Lethality During Coinfection
Previous observations by Carlson, et al. revealed that S. aureus strains capable of
producing various exotoxins demonstrated strong infectious synergism with C. albicans
during IAI (59). S. aureus strain JE2 (derived from the USA300 isolate LAC) is a well
characterized and robust producer of secreted toxins with an intraperitoneal LD50 of 5 x
108 CFU (97). Therefore, we administered a sub-lethal dose of S. aureus JE2 to observe
potential synergistic effects during co-infection. Intraperitoneal (i.p.) inoculation of
Swiss-Webster mice with 8 x 107 CFU S. aureus (SA, yellow) led to some morbidity by 1
day post-inoculation (d p.i.) (slightly ruffled fur) but ultimately these mice cleared the
infection with no mortality (Figure 2-2). Similarly, infection with C. albicans alone (CA,
blue) led no observable morbidity and no mortality (Figure 2-2). However, co-infection
at this same dose with these microbes was striking (CA+SA, green). Mice began
exhibiting symptoms of morbidity around 12 h p.i. By approximately 16-20 h p.i. 80% of
mice had succumbed to infection. Therefore, the rapid onset of morbidity and mortality in
co-infected mice may be explained by the relatively high toxigenic activity of this S.
aureus strain (among other strain-dependent differences). However, S. aureus JE2 was
non-lethal during monomicrobial infection. Thus, we hypothesized that co-infection with
C. albicans may actually augment toxin expression.

The agr Quorum Sensing System Is Enhanced During Coculture
The staphylococcal agr quorum sensing system is tightly linked with toxin
regulation. As part of a two-component signal transduction system, upon its activation
AgrA is phosphorylated and drives expression of RNAIII, the major toxin effector, by
binding to the P3 promoter. We constructed an agrA reporter strain in JE2 based on
plasmid pDB22 [S. aureus(pDB22)] with the P3 promoter fused to GFP to be used as a
proxy of toxin production. During planktonic culture in TSB-g, GFP levels were absent at
early time points, consistent with the fact that activation of the agr system is cell density
dependent (Figure 2-3A). At ~8 h p.i. reporter activities were noticeable in both
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Figure 2-2. Co-infection with a USA300 strain leads to robust early synergistic
mortality.
Mice (n = 8 per group) were inoculated i.p. with 1.75 x 107 CFU C. albicans (CA, blue),
8 x 107 CFU S. aureus (SA, yellow), or both pathogens simultaneously at these doses
(CA+SA, green). Survival was monitored up to 10 d p.i. Data is derived from duplicate
experiments of 4 mice per group and combined. Significance was assessed using a
Wilcoxon rank sum test. ***, P < 0.001.
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Figure 2-3. P3-reporter activity, a surrogate of staphylococcal agr activation, and
red blood cell lysis is enhanced during co-culture with C. albicans.
(A) A P3-GFP reporter strain of S. aureus [(S. aureus(pDB22)] was incubated alone or
with C. albicans over a 24 h time course. At each time interval, 100 μl of culture was
removed in triplicate, added to a 96-well plate, and fluorescence captured at 488 nm/515
nm. C. albicans only and S. aureus lacking pDB22 were also included as controls. Values
represent the mean AFU of triplicate experiments ± SEM. (B) Aliquots from reporter
experiments were also visualized by fluorescence microscopy at 16 h by counter-staining
cells with the DNA stain Syto62 and capturing GFP fluorescence with a GFP/Texas Red
filter set. Images are representative of 3 independent repeats. (C) CFU levels (C.
albicans, blue; S. aureus, yellow) of monomicrobial and polymicrobial cultures at 16 h
growth were assessed by microbiological plating on selective media. Counts were
assessed for significance using a Mann-Whitney U test. (D) Hemolytic activity was
assessed from monomicrobial (C. albicans or S. aureus) and polymicrobial (C. albicans +
S. aureus) cultures by placing 20 μl of filtered culture supernatant into wells on a Sheep’s
blood agar plate. Images were captured after incubation at 37°C for 16 h and
representative of 3 independent repeats. (E) agr activity was quantitatively assessed by
the capacity of supernatants from monomicrobial (C. albicans, blue; S. aureus, yellow) or
polymicrobial cultures (green) to lyse rabbit erythrocytes. Values are expressed as the
mean of triplicate experiments ± SEM. Significance of synergism was compared using a
Student’s t-test. *, P < 0.05.
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monomicrobial and polymicrobial cultures harboring S. aureus(pDB22). However, at 12
and 16 h reporter activity of polymicrobial cultures were significantly higher (as much as
doubled) than during monomicrobial growth, indicating augmented activation of the
major signaling pathway controlling toxin production (Figure 2-3A). To confirm these
findings, aliquots from cultures were removed and imaged by fluorescence microscopy,
revealing qualitatively enhanced GFP signal in polymicrobial as compared to
monomicrobial cultures (Figure 2-3B). To address whether organism burden was
drastically altered during polymicrobial growth at the 16 h time point, C. albicans, S.
aureus or the two combined were grown in TSB-g and plated on selective
microbiological media. Enumeration revealed nearly identical C. albicans and S. aureus
CFU levels between both monomicrobial and polymicrobial cultures (Figure 2-3C).
However, cell-free supernatants added to TSA-blood revealed strikingly higher levels of
hemolysis from polymicrobial cultures, suggesting enhanced levels or activity of
hemolytic toxins during growth with C. albicans, consistent with GFP reporter results.
Importantly, cell-free supernatants derived from C. albicans cultures were devoid of
hemolytic activity (Figure 2-3D). Augmented lysis of rabbit red blood cells (a cell type
exquisitely sensitive to α-toxin) from polymicrobial cultures further confirmed this
phenotype quantitatively (Figure 2-3E) (98).

agr-Regulated Genes and Corresponding Proteins Are Increased During Coculture
In order to determine whether downstream agr-regulated genes were also being
increased during polymicrobial growth, we assessed transcriptional responses of S.
aureus or C. albicans in combination with S. aureus by qPCR. By rupturing cells with
lysostaphin (an enzyme that breaks down staphylococcal cell walls) we were able to
selectively isolate S. aureus RNA so that the amounts of recovered staphylococcal
nucleic acid between monomicrobial and polymicrobial cultures could be made
equivalent. qPCR analysis revealed increases in hld (encoding for δ-toxin, 5.1-fold), hla
(α-toxin, 80-fold), RNAII (agr operon, 2.5-fold), agrA (quorum sensing regulator, 7fold), and spa (surface protein A, -0.5-fold) (Figure 2-4A). As RNAII, hld, hla, and agrA
itself are downstream targets of agr activation, these results provide further evidence of
augmented agr activity during growth with C. albicans. The exception to this gene list
was the down-regulation of spa. However, it has been well documented that surface
protein A is negatively correlated with agr activation, and thus its down-regulation is in
agreement with previous observations (99). Similar regulation of these quorum sensing
effectors was also conserved at the protein level as evidenced by Western blotting of cellfree supernatants (Figure 2-4B). Phenol soluble modulins (of which δ-toxin is a member)
are small, ethanol soluble peptides that prove somewhat difficult to resolve by
electrophoresis (100, 101). Therefore, we utilized an ethanol precipitation step and
subsequent drying to fractionate supernatants to improve toxin recovery as described
previously (100). Densitometric analysis demonstrated that α-toxin (37 kDa) was
increased by 8.2-fold, δ-toxin (3 kDa) was increased by 4.3-fold, and Protein A (56 kDa)
was decreased by 0.7-fold, further explaining increased in vitro hemolytic activity.
Protein expression levels were in line with transcriptional results, except for α-toxin,
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Figure 2-4. agr-associated genes and staphylococcal toxins are increased during
polymicrobial growth with C. albicans.
(A) Quantitative real-time PCR (qPCR) was performed to assess expression of
staphylococcal quorum sensing related genes during monomicrobial vs. polymicrobial
culture. Values were calculated using the ΔΔCT method and normalized to reference gene
gyrB. Data is expressed as normalized fold-expression of polymicrobial vs.
monomicrobial cultures and the mean of 3 independent experiments. (B) Representative
image (n = 3) of Western blot performed on 40 μl of cell-free supernatants derived from
C. albicans (CA) only, S. aureus (SA) only, or polymicrobial (CA+SA) cultures for αtoxin, δ-toxin, and Protein A.
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which was lower than anticipated by qPCR and may indicate involvement of other
mechanisms of post-transcriptional control (102).
⍺-Toxin Is Required for Lethal Synergism
These findings revealed that agr activity was elevated during polymicrobial
growth, although it was undetermined whether agr was required for augmented toxin
secretion during co-culture with C. albicans. Therefore, we assessed toxin secretion of an
ΔagrA mutant during polymicrobial growth. Using the qualitative blood agar-based and
quantitative RBC lysis assays, we confirmed that indeed enhanced toxin expression
during co-culture is agrA-dependent, as growth with C. albicans was unable to rescue
this agr defect (Figure 2-5A, B). Given the strong up-regulation of ⍺-toxin observed
during in vitro growth with C. albicans, we hypothesized that this toxin may drive
synergistic lethality during co-infection. Use of an isogenic Δhla strain revealed loss of
lytic activity against sheep RBCs, indicating that the in vitro lytic phenotype is hladependent (Figure 2-5C). However, complementation of hla on a low copy plasmid
(Δhla-phla) restored the lytic phenotype to wild-type levels. Importantly, both the WT
and complemented strains exhibited elevated RBC lysis during co-culture with C.
albicans (Figure 2-5C). An ⍺-toxin specific enzyme-linked immunosorbent assay
(ELISA) used to assess toxin levels in culture supernatants quantitatively confirmed these
results (Figure 2-5D). ⍺-toxin was required for early synergistic lethality during IAI as
co-infection with the Δhla mutant was avirulent as compared to co-infection with WT
and Δhla-phla strains (Figure 2-5E). As expected, co-infection with the ΔagrA mutant
and monomicrobial infections were non-lethal over this same time course (Figure 2-2,
Figure 2-5E).
The agr System and ⍺-Toxin Production Is Increased During Coinfection
We next wished to determine whether agr was engaged early during infection
prior to presentation of severe symptomatology. Mice were inoculated with either S.
aureus, S. aureus(pDB22), C. albicans and S. aureus, or C. albicans and S.
aureus(pDB22), sacrificed 8 h p.i., and underwent peritoneal lavage. Analysis of
microbial burden in the lavage fluid revealed that, similar to in vitro culture,
staphylococcal burden was similar in both monomicrobial and polymicrobial infections
(Figure 2-6A). Microscopic analysis of the lavage fluid revealed the presence of C.
albicans and S. aureus, as well as robust mononuclear infiltrate. The S. aureus(pDB22)
strain demonstrated agr activity, as evidenced by GFP signal, but only sparingly and
mostly associated with resident immune cells (Figure 2-6B). In contrast, S.
aureus(pDB22) co-inoculated with C. albicans demonstrated frequent GFP signal and
when juxtaposed near C. albicans (Figure 2-6B). While this result is qualitative, it
visually demonstrates that the agr system is indeed engaged in the murine peritoneal
cavity. Importantly, at this early time point there was a nearly 3-fold increase in ⍺-toxin
(Figure 2-6C) and roughly 4-fold increase in PGE2 (Figure 2-6D) levels observed in
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Figure 2-5. Increased S. aureus α-toxin during growth with C. albicans is agrdependent and α-toxin is required for lethal infectious synergism during IAI.
(A) Hemolytic activity of monomicrobial and polymicrobial cell-free supernatant (20 μl,
16 h time point) using S. aureus (SA) and a ΔagrA deletion mutant was assessed using a
Sheep’s blood agar assay. Representative image of 3 independent repeats. (B) Lytic
activity of culture supernatants against rabbit erythrocytes. Data is expressed as the mean
(n = 3 experiments) ± SEM. *, P < 0.05. (C) Assay was performed as in panel A using S.
aureus, Δhla deletion mutant, and an hla complemented strain (Δhla-phla).
Representative image of 3 independent repeats. (D) Production of ⍺-toxin as measured by
ELISA during co-culture of C. albicans (green bars) with wild-type S. aureus (yellow
bar), Δhla (red bar, n.d.), or Δhla-phla (yellow hashed bar). Data is expressed as the
mean ± SEM. *, P <0.05; ** P < 0.01. (E) Mice were co-infected i.p. with C. albicans
(CA) and wild-type S. aureus (green line), ΔagrA (purple line), Δhla (red line), or Δhlaphla (black line) using established inocula. Mortality was monitored for up to 10 d p.i.
Data is derived from duplicate experiments of n = 4 mice per group and combined.
Significance was assessed using a Wilcoxon rank-sum test. ***, P < 0.001.
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Figure 2-6. The S. aureus agr quorum sensing system is engaged during IAI and
polymicrobial infection leads to synergistic increases in PGE2 and α-toxin.
(A) Mice (n = 4 per group) were inoculated with S. aureus (SA, yellow) or C. albicans
(CA, blue) alone (mono) or with both pathogens simultaneously (poly) using established
inocula. Mice were sacrificed 8 h p.i. and subjected to peritoneal lavage, and lavage fluid
was plated on selective media. CFU counts are expressed as the median. (B) Mice were
inoculated as described for panel A, except with strain S. aureus(pDB22), containing the
GFP-P3 reporter. An aliquot of lavage fluid was assessed 8 h p.i. by fluorescence
microscopy using DIC/GFP filter sets. Blue arrows depict hyphal filaments among
peritoneal cells. Images are representative of at least 5 fields of view. (C) Levels of ⍺toxin present in peritoneal lavage fluid 8 h p.i. during monomicrobial (CA, blue; SA,
yellow) and polymicrobial (CA+SA, green) infection as measured by ELISA. Data are
cumulative of two independent repeats and expressed as the mean ± SEM. **, P<0.01;
n.d., not detected. (D) PGE2, as a measure of PGE metabolites (PGEM), present in the
peritoneal lavage fluid 8 h p.i. as measured by competitive EIA. Data are cumulative of
two independent repeats and expressed as the mean ± SEM. ***, P < 0.001. Synergistic
significance was determined using a Mann-Whitney test (CFU) and Student’s t test (⍺toxin, PGEM).
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peritoneal lavage fluid of co-infected mice. Mice infected with C. albicans alone
demonstrated modest PGE2 and no measurable α-toxin in the lavage fluid, demonstrating
assay specificity.

Passive Immunization with an Anti-⍺-Toxin Antibody Is Protective Against
Synergistic Lethality
Lastly, we wanted to determine whether blockade of ⍺-toxin was sufficient to
elicit protection during polymicrobial IAI. Therefore, we passively immunized mice 24 h
prior to co-infection with the anti-⍺-toxin specific monoclonal IgG1 antibody (mAb)
MEDI4893* at doses of 15 and 45 mg/kg or isotype control R347 (82). Mice receiving
control antibody succumbed to co-infection within 1 day, similar to that previously
observed in untreated mice (Figure 2-7A). Mice receiving MEDI4893* at 15 mg/kg
exhibited a slight delay in mortality (~ 2 d p.i.). However, approximately 50% of these
mice succumbed to infection by 3 d p.i. and this increased to 70% by 8 d p.i. Importantly,
mice receiving MEDI4893* at a dose of 45 mg/kg exhibited no mortality until 4 d p.i.
and an overall mortality rate of only 30% (Figure 2-7A). Thus, passive administration of
MEDI4893* improves survival during polymicrobial IAI. We next wanted to determine
whether administration of ⍺-toxin during infection with C. albicans was sufficient to
cause synergistic lethality. First, a non-lethal i.p. dose of ⍺-toxin (0.5 μg) was determined
(Figure 2-7B). However, co-inoculation of mice with C. albicans and 0.5 μg ⍺-toxin did
not recapitulate the lethal synergy between C. albicans and S. aureus (Figure 2-7C).
Collectively, these results demonstrate that the staphylococcal regulator agr is robustly
increased during fungal-bacterial co-infection and that α-toxin is necessary but not
sufficient in mediating early lethal synergism with C. albicans.

Conclusions
In nature, microorganisms rarely grow as single species but instead most exist as
polymicrobial communities characterized by mutualistic, parasitic, commensalistic, or
antagonistic interactions. With the advent of high throughput sequencing technologies,
we have now begun to realize the tremendous microbial diversity that exists, not only in
the environment, but also within the human biome. Although we are rapidly amassing
incredible amounts of data regarding microbiome composition, functional and
mechanistic relationships between microbial consortia and human host are only now
being explored in depth. Furthermore, the boundaries of Koch’s postulates are being
challenged, as some disease phenotypes are now realized to result from a complex set of
microbial virulence mechanisms, partially governed by microbe-microbe interactions.
One extreme example is “lethal synergism”, in which co-infection mediates mortality of
otherwise survivable infections with each microbe independently. This phenomenon has
been previously reported in a variety of biological systems but is perhaps best
characterized by fungal-bacterial IAI with C. albicans and S. aureus.
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Figure 2-7. ⍺-toxin is necessary but not sufficient to drive infectious synergism
during IAI.
(A) Mice (n = 4 per group) were inoculated i.p. with 45 mg/kg human IgG1 isotype
control antibody R347 (green) or an IgG1 antibody specific for ⍺-toxin (MEDI4893*) at
doses of 15 mg/kg (blue) or 45 mg/kg (red) 24 h prior to i.p. coinfection with C. albicans
and S. aureus. Survival was monitored for up to 10 d p.i. Data are from duplicate
experiments of 4 mice per group and were combined. Significance was assessed using a
Wilcoxon log rank test. (B) A range of ⍺-toxin doses were injected i.p. into groups of
mice (n = 4) to determine lethality. (C) Swiss-Webster mice were inoculated i.p. with 0.5
g of ⍺-toxin, immediately followed by i.p. injection of either sham PBS (blue) or C.
albicans (red). Data are representative of duplicate experiments with 4 mice per group,
and data were combined. *, P < 0.05; ***, P < 0.01; ***, P < 0.001.
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Our lab has explored the interaction between C. albicans and S. aureus
extensively. Previous studies revealed that indeed, C. albicans influenced global protein
expression during growth with S. aureus, including modulation of several putative
virulence factors (47). It was also determined that S. aureus preferentially binds the
invasive hyphal form of C. albicans via the candidal adhesin Als3p and this interaction
allows for enhanced mortality and systemic dissemination from the oral cavity during
oropharyngeal candidiasis. Furthermore, during biofilm growth, C. albicans confers highlevel vancomycin resistance to S. aureus by forming a drug permeability barrier via
elaboration of carbohydrate dense extracellular matrix (46, 48). These studies highlight
the highly dynamic relationship between these microbes.
Data in this manuscript build off of recent efforts by our lab seeking to define the
mechanism by which C. albicans augments S. aureus infection during polymicrobial IAI,
as observed by Carlson et al. many years prior. Initial studies determined that host
inflammation, including the eicosanoid PGE2 and cytokine IL-6, was synergistically
exacerbated in mice challenged with both microbes simultaneously as compared to
monomicrobial infection and correlated with lethal outcome (67). Furthermore,
protection was mediated by anti-inflammatory administration and subsequent PGE2
blockade (62, 87). Using various transcriptional regulator mutants, lethal infection was
surprisingly independent of C. albicans morphological transition, as other experimental
C. albicans disease models are almost universally dependent on morphogenetic
regulation (66). This observation was further confirmed by the fact that various other
Candida species mediate synergistic lethality independent of capacity to form true
hyphae during IAI (67). Importantly, all of these studies were conducted using S. aureus
strain NRS383 (USA200), which is grouped into the CC30 clonal complex (50). While
synergistic lethality was achieved during co-infection with this strain, kinetics (~3 d p.i.)
were modest compared to infection with JE2 (<1 d p.i.) in this study. Interestingly, CC30
strains are documented to have very low to no production of α-toxin under in vitro
conditions, in some cases due to a premature stop codon within hla (103). NRS383
exhibits a weak zone of hemolysis on blood agar, further emphasizing the importance of
staphylococcal α-toxin in driving lethal synergism with C. albicans.
The major staphylococcal regulator of ⍺-toxin production is indeed governed by
agr-dependent signaling. However, several reports suggest contribution of agrindependent mechanisms regulated via the sarA and saeRS networks (104). In support of
this, clinical isolates that are agr negative have been observed to activate hla transcription
in vivo. Similarly, deletion of sae causes loss of hla transcription, despite an intact agr
regulon (105). Results from our previous study of polymicrobial IAI demonstrate that S.
aureus disseminates to distant tissues (including the brain) quickly and, at later time
points reaches greater numbers during polymicrobial as compared to monomicrobial
infection (66). Thus, it is possible that delayed activation of these alternative ⍺-toxin
regulators at sites of dissemination in vivo may explain lethality with strains exhibiting
low hemolytic activity in vitro. Given that a relatively large fraction (15-60%) of HAMRSA strains are agr-defective, it will be interesting to delineate the role of these
alternative ⍺-toxin regulators in driving synergistic lethality and their potential activation
during growth with C. albicans (106).
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Experiments utilizing the isogenic Δhla strain during co-infection demonstrated a
clear requirement for α-toxin to mediate infectious synergism. These findings were
corroborated by Rauch et al, in which loss of hla during high-dose monomicrobial
peritoneal challenge with S. aureus strain Newman dramatically improved survival rates
as compared to wild-type infection (97). Moreover, blockade of ⍺-toxin using the
investigational neutralizing antibody MEDI4893* further confirmed the importance of
this virulence determinant in driving mortality during IAI. MEDI4893* exerts its effects
by not only inhibiting engagement of ⍺-toxin to its host receptor ADAM10, but also by
preventing oligomerization of the mature heptamer required for membrane pore
formation and lytic activity (107). Aside from the clear protective effects demonstrated
against polymicrobial IAI in this study, MEDI4893* has also demonstrated efficacy in
both immunocompetent and immunocompromised animal models, including necrotizing
pneumonia, dermonecrosis, and sepsis (82, 108-110). Although prophylactic treatment
with MEDI4893* did not confer 100% survival in this study, it did significantly delay
mortality to 2 (15 mg/kg) and 4 d p.i. (45 mg/kg), respectively, which could allow for an
extended therapeutic window for antimicrobial administration. Although beyond the
scope of this work, future studies to determine whether MEDI4893* can be given
therapeutically to confer protection post-infection are warranted. In any case, passive
immunization against ⍺-toxin is an intriguing possibility for those at elevated risk of IAI,
including abdominal surgery, peritoneal dialysis, or tertiary peritonitis patients.
Cohen et al. recently demonstrated that α-toxin is necessary and sufficient for S.
aureus lethal synergy during lung co-infection with Gram-negative opportunists (111).
However, it is still unclear whether α-toxin is sufficient to mediate lethal synergism
during C. albicans infection or if other components of S. aureus are also required.
Carlson had previously observed that inoculation of C. albicans with cell-free spent
culture supernatants of S. aureus could induce synergistic lethality, suggesting that
staphylococcal secreted products (e.g. toxins) were perhaps implicated (72). The potency
of α-toxin is impressive, with the LD50 being reported as ~1 μg via systemic injection or
intranasal challenge; an intradermal dose of 10 μg is sufficient to induce large skin
lesions (82, 84, 112). Despite initial signs of morbidity, inoculation of mice with C.
albicans followed by a sub-lethal dose of purified α-toxin was unable to recapitulate
synergistic mortality (Figure 2-7). There are several reasons why this may be the case. It
is possible that a sub-lethal bolus dose of toxin is not sufficient to potentiate effects with
C. albicans. It is also equally likely that sustained expression of S. aureus toxin during
infection is required to augment co-infection. Alternatively, α-toxin may only potentiate
host- or microbe-derived signals present during infection with intact fungal or bacterial
pathogens or may be required to be present with C. albicans at the immunological
synapse. Additionally, Carlson’s observations may be explained by the presence of
multiple toxins or shed cell wall material present in the culture supernatant that were not
completely inactivated by heating. These soluble factors may maintain pro-inflammatory
activity to elicit robust PGE2 and cytokine production during co-infection by stimulating
pattern recognition receptors (PRRs) and serving as danger-associated molecular patterns
(DAMPs).
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This study describes the novel finding of a human pathogenic fungus engaging
virulence of a bacterial pathogen with dire consequences for the host. That said, crossspecies and cross-domain quorum sensing communication has been observed in several
other reports. For example, Bamford, et al. demonstrated that the diffusible chemical
signal AI-2, derived from the luxS gene of the ubiquitous oral commensal Streptococcus
gordonii, enhances C. albicans hypha formation during polymicrobial biofilm growth
(113). Perhaps one of the best well-studied interactions occurs between C. albicans and
Pseudomonas aeruginosa, whereby the bacterial quorum sensing molecule 3-oxo-C12
inhibits the fungal yeast-to-hypha transition (114). P. aeruginosa also attaches to the
fungal surface, secreting a variety of fungicidal substances (phenazine, pyocyanin, etc.)
(15). In response, C. albicans secretes its own quorum sensing compound farnesol that
has antibacterial activity (25). Therefore, it is not unreasonable to speculate that secreted
fungal quorum sensing molecules (or otherwise) may elicit toxigenic responses by S.
aureus via quorum sensing induction. Indeed, at supra-physiologic concentrations,
farnesol does exhibit anti-staphylococcal effects (27). Although apparent lack of an
antagonistic relationship between these microbes during co-culture, as evidenced by
previous imaging studies, further clouds this hypothesis (47).
It is possible that cell-cell contact, and not necessarily a secreted factor, mediates
the toxigenic response in S. aureus. Previous studies from our lab have demonstrated that
the major adhesin responsible for C. albicans-S. aureus interactions is the candidal
protein Als3p (50). This fact, coupled with the ability of several transcriptional regulator
mutants of C. albicans incapable of hypha formation to still promote lethal synergism
during IAI, suggests an alternative mechanism as these strains would also be predicted to
not express hypha-associated Als3p (66, 67). Furthermore, co-infection with a Δ/Δals3
mutant of C. albicans still exhibited synergistic lethality with S. aureus (JE2) during
experimental IAI (unpublished studies). That said, maximal engagement of a soluble
factor to its potential target in vivo may occur if both microbes maintain intimate contact.
We also cannot rule out the possibility that an environmental factor or host component
mediates enhanced toxin secretion in vivo. It is well known that the agr system is
sensitive to several environmental stimuli, including pH; the pH of the abdominal cavity
during C. albicans peritonitis is slightly alkaline (68, 115). Thus, it is possible that
anatomical niches within the abdomen buffer the acidic end products of staphylococcal
metabolism, thereby maintaining neutral pH levels optimal for sustained agr activation.
C. albicans infection may also generate host or fungal byproducts that S. aureus can use
as metabolic substrates or signaling molecules to up-regulate toxin expression.
Collectively, these results demonstrate that C. albicans augments S. aureus
virulence via an agr- and α-toxin-dependent mechanism during polymicrobial IAI,
resulting in devastating consequences for the host. These findings are important given the
frequency with which these microbes are co-isolated from biologic (e.g. vagina,
gastrointestinal tract, skin, oropharynx) and artificial (e.g. indwelling catheters) sites
during colonization or infection. Furthermore, systemic disease caused by Candida
species is associated with mortality rates exceeding 40% even with appropriate therapy
(116). Given our observations, it is possible that these unacceptably high mortality rates
may not only result from fungal infection alone, but may be engaging virulence
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mechanisms in otherwise commensal microbes or co-infecting pathogens (60, 117, 118).
Novel strategies to inhibit fungal-bacterial quorum sensing cross-talk or its downstream
effectors may be warranted to better manage IAI, including use of an antibody-mediated
vaccine against staphylococcal α-toxin in at risk patient populations to limit incidence of
severe sepsis.
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CHAPTER 3. CANDIDA ALBICANS IMPACTS STAPHYLOCOCCUS AUREUS
⍺-TOXIN PRODUCTION VIA EXTRACELLULAR ALKALINIZATION*

Introduction
Candida albicans, an opportunistic polymorphic fungus, and Staphylococcus
aureus, a ubiquitous bacterial pathogen, rank among the top organisms responsible for
life-threatening invasive disease. Not only do these pathogens cause significant morbidity
and mortality on their own, evidence for their existence as part of polymicrobial consortia
has surfaced. For instance, C. albicans and S. aureus have been co-isolated from a variety
of biotic and abiotic surfaces, including central venous catheters, prosthetic implants, the
skin, and mucosal layers (75, 119). Moreover, they have been co-associated with several
polymicrobial diseases, including burn wound superinfection, ventilator-associated
pneumonia, urinary tract infection, cystic fibrosis, and bloodstream infection (42-44,
120). However, perhaps the most comprehensive line of investigation of this particular
co-infection has focused on their role during intra-abdominal infection (IAI).
IAI is a spectrum of diseases characterized by microbial invasion and subsequent
inflammation of the abdominal cavity (55). Mortality rates for such infections typically
range between 10-30%; however, mortality rates involving a fungal pathogen (e.g. C.
albicans) can approach 80%, even with appropriate treatment (56, 57). Using a murine
model of IAI, a series of studies by Carlson, et al. demonstrated that C. albicans
enhanced the virulence of S. aureus, as co-infection reached 100% mortality within days
p.i. while monomicrobial infection with either pathogen was non-lethal (59). Studies
designed to titrate various inoculating doses of C. albicans and S. aureus during coinfection revealed that this apparent synergism was not mutual, as C. albicans virulence
was not augmented by low doses of S. aureus (60). Synergistic mortality rates were found
to be dependent on various toxins produced by S. aureus (71). Although these studies
failed to delineate which specific S. aureus toxin was responsible, they established their
important role in driving pathogenicity in the context of polymicrobial IAI.
Toxin expression in S. aureus is governed by a complex set of transcriptional
regulators that respond to endogenous and environmental stimuli. Perhaps the best wellcharacterized mechanism is driven by the accessory gene regulator (agr) quorum sensing
system that is activated in a cell density-dependent manner. The agr operon is composed
of four genes encoding for AgrA, AgrB, AgrC, and AgrD proteins (121). AgrD serves as
the immature signal peptide that is proteolytically processed and secreted by membrane
bound AgrB, releasing the mature signal molecule auto-inducing peptide 2 (AIP-2). AIP2 can be sensed by the surface bound receptor and histidine kinase AgrC that
phosphorylates and activates the transcription factor AgrA. Activation of AgrA
___________
*Reprinted from final submission with open access permission. Todd OA, Noverr MC,
Peters BM. 2019. Candida albicans Impacts Staphylococcus aureus Alpha-Toxin
Production via Extracellular Alkalinization. mSphere 4.(122).
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simultaneously up-regulates expression of the agr operon completing a positive feedback
loop, while also ultimately down-regulating colonization factors (e.g. adhesins) and upregulating virulence factors including toxins (80, 121). While agr is undoubtedly induced
as a consequence of quorum development, it is also highly susceptible to environmental
factors including high salt, glucose, subinhibitory antibiotic concentrations, and pH (115,
123).
Our laboratory has recently demonstrated that during in vitro growth, C. albicans
has the capacity to activate the agr regulon, leading to exacerbated production of ⍺-toxin,
a potent staphylococcal virulence determinant capable of lysing a variety of host cells,
causing tight-junction loss, and activating numerous innate pro-inflammatory pathways
(65). Moreover, this virulence factor was crucial for driving lethal synergism during
polymicrobial IAI. By using a combination of genetic and functional assays, the objective
of this study was to attempt to elucidate the mechanism by which C. albicans activates
agr signaling and ⍺-toxin production by S. aureus and to determine the extent that other
non-albicans Candida (NAC) species can augment ⍺-toxin release (65). In the course of
conducting these studies, we discovered that modulation of the extracellular pH by C.
albicans creates an optimal environment for robust induction of the staphylococcal agr
system further highlighting how complex ecological signals may intersect with virulence
during this prevalent fungal-bacterial interaction.

Materials and Methods

Strains and Growth Conditions
Candida albicans SC5314 (referred to as CA) was used as the wild-type isolate
throughout this work. The alkalinization-deficient mutant stp2/ (SVC17) and its
isogenic revertant strain STP2-REV (SVC19) were kind gifts from Dr. Michael Lorenz
(University of Texas Health Science Center) (124). The non-albicans Candida (NAC)
species C. glabrata CBS138 (CG), C. dubliniensis CD36 (CD), C. parapsilosis CDC317
(CP), C. tropicalis MYA3404 (CT), and C. krusei 81-B-5 (CK) were used as speciesrepresentative strains (67). JE2, a USA300 isolate, was obtained from the Biodefense and
Emerging Infectious (BEI) Research Resources repository and used as the wild-type S.
aureus strain in this work and is referred to as SA. A S. aureus reporter strain [S.
aureus(pDB22)] containing plasmid pDB22 (containing the P3 promoter fused to
GFPmut2 and an erythromycin resistance cassette) was also used in this work (125). All
strains were maintained as 20% glycerol stocks at -80°C.
Candida strains were streaked onto yeast peptone dextrose (YPD) agar and grown
at 30°C. A single colony was inoculated in YPD broth and incubated overnight at 30°C
with shaking at 200 rpm. S. aureus strains were streaked on trypticase soy agar (TSA)
(with 10 g/mL erythromycin added as needed). Single colonies were inoculated in TSB
and grown overnight at 37°C with shaking at 200 rpm. Aliquots (500 L) were washed
3X with PBS and cell concentrations adjusted to 1 x 107 CFU/mL. A 1:100 dilution was
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made into 5 mL 0.6X TSB + 0.2% glucose (TSB-g) with the following groups: CA or SA
(monomicrobial) and CA+SA (polymicrobial). PBS (50 L) was added to monomicrobial
cultures. Cultures were incubated at 37°C with shaking at 200 rpm and aliquots removed
at 16 h post-inoculation (p.i.). Mono- and polymicrobial cultures using the alkalinizationdeficient mutant and revertant strains were prepared as above, except TSB-g was adjusted
to pH 6 prior to inoculation and cultures were incubated for 24 h.

agr Reporter Assay
Mono- and polymicrobial cultures were prepared as described above using CA
and/or S. aureus(pDB22) (10 g/mL erythromycin added for plasmid maintenance). At
16 h p.i., 100 μL aliquots were removed in triplicate from cultures and added to wells of
96-well black microtiter plate. Fluorescence (488 nm excitation, 525 nm emission) was
measured using a plate reader (Synergy, Biotek). Experiments were repeated in triplicate
and results expressed as the mean arbitrary fluorescence units (AFU)  SEM.

Blood Agar Lysis Assay
Cultures were prepared as described above and at 16 h p.i., 5 mL aliquots were
centrifuged at 5000 rpm to pellet cells, and supernatants sterilized using 0.2 m syringe
filters. Sterile supernatants were concentrated 20x by ethanol precipitation. Holes were
punched in blood agar plates (TSA with 5% sheep’s blood) using a sterile pipette tip.
Concentrated supernatant (20 µL) was added to wells and plates were incubated at 37°C
for 24 h. Plates were photographed using a digital scanner (EPSON Perfection V700
Photo).

pH Buffering
pH buffering experiments were done by the same culture set-up described above,
with the following changes: 100 mM MOPS was added to 0.6X TSB + 0.2% glucose and
the media was adjusted to varying pH (5.5, 6, 6.5, 7,7.5, and 8) using 5 N HCl or NaOH
as required. Aliquots (500 μL) of overnight cultures of CA and S. aureus(pDB22) were
washed with PBS and adjusted to 1 x 107 CFU/mL. A 1:100 dilution was made into 5
mL MOPS-buffered TSBg at each pH tested. Mono- and polymicrobial cultures were
incubated for 16 h at 37°C with shaking at 200 rpm.

Kinetic agr Activation Assay
S. aureus(pDB22) was grown overnight in MOPS-buffered 0.6X TSB-g, pH 5.5
to inactivate agr. Additionally, S. aureus (JE2) and C. albicans were grown overnight in
MOPS-buffered 0.6X TSB-g, pH 7. Cultures were centrifuged at 4000 rpm for 3 min.
Supernatant from the JE2 and C. albicans cultures were collected and filter sterilized.
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Cells from S. aureus(pDB22) grown at pH 5.5 were washed with PBS and adjusted to 1 x
1010 CFU/mL. Cells were added to 1 mL 5X MOPS-buffered TSB-g, pH 7 to a final
concentration of 2 x 108 CFU/mL. 4 mL of either S. aureus spent, C. albicans spent, or
fresh media was added to the cells along with 10 g/mL erythromycin (for plasmid
maintenance). Cultures were incubated at 37°C with shaking at 200 rpm. At 20 min
intervals, 100 μL aliquots were removed and fluorescence was measured as above.
Experiments were repeated in triplicate and results expressed as the mean AFU  SEM.
⍺-Toxin ELISA
S. aureus ⍺-toxin was quantified by ELISA, as described previously (65). Briefly,
96-well plates were coated with 0.1 μg/mL MEDI4893* diluted in coating buffer and
incubated overnight at 4°C. All wash steps were carried out with PBS-0.05% Tween 20
(PBS-T). Plates were washed and blocked with SuperBlock (Pierce) for 1 h at room
temperature. 50 L of diluted filter-sterilized supernatant (taken at 16 h p.i.) was added to
wells, with serial dilutions of native alpha-toxin included as the standard curve. The
plates were incubated for 1 h at room temperature and then washed. 2 μg/mL affinitypurified rabbit polyclonal anti-⍺-toxin antibody was added to wells and the plates were
incubated for 1 h at room temperature. Plates were washed, followed by addition of a
1:10,000 dilution of Affinipure HRP-coupled goat anti-rabbit IgG detection antibody
(Jackson Immuno Research). Plates were incubated for 1 h at room temperature and
washed. TMB substrate was added to wells and color was allowed to develop in the dark
for 10 min. 100 μL ELISA stop solution (0.2 M H2SO4) was added and wells were read at
450 nm using a spectrophotometer (Synergy, Biotek). Culture supernatants from S.
aureus NE1354 Δhla were used as background controls and were subtracted from sample
wells to exclude any non-specific binding of antibody by protein A. The experimental
values were extrapolated to the standard curve. Experiments were completed in triplicate
and shown as mean concentration ± SEM.

CFU Analysis
CFU enumeration was done by serial plating of culture media onto YPD
containing 20 μg/mL nafcillin (for Candida enumeration) and TSA containing 2.5 μg/mL
amphotericin B (for S. aureus enumeration) via the drop-plate method (48). Plates were
incubated overnight at 37°C, enumerated, and expressed as CFU/mL. CFU values are
representative of 3 independent repeats and represented as median  SEM.
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Results
C. albicans Augments Staphylococcal ⍺-Toxin and Does Not Complement agr
Signaling in Trans
Similar to previously reported findings (65), co-culture of C. albicans and S.
aureus led to elevated hemolytic toxin production when compared to mono culture, as
assessed by a functional hemolytic assay on Sheep’s blood agar (Figure 3-1A).
Unsurprisingly, monoculture of C. albicans did not demonstrate lysis as this fungus is not
commonly reported to lyse red blood cells on microbiological agar (Figure 3-1A). While
the regulation of virulence factor production in S. aureus is multi-factorial, the agr
quorum sensing system plays a major role in governing increased toxin expression. In
order to confirm that the agr system was more robustly activated during co-culture, a P3GFP reporter system (the P3 promoter is a target of phosphorylated and activated AgrA
and ultimate driver of toxin expression) was employed. Indeed, reporter analysis
indicated approximately a 2.5-fold induction of agr (Figure 3-1B), which correlated with
~4-fold production of ⍺-toxin as measured by specific ELISA (Figure 3-1C). These
results were consistent with those in Figure 3-1A given that the hemolytic phenotype
observed on Sheep’s blood agar is dependent on ⍺-toxin activity.
The next logical line of investigation was to determine whether C. albicans may
be producing a protein or other small molecule that could be activating the agr system in
S. aureus leading to up-regulation of toxin. Loss of agrA is predicted to largely ablate
quorum sensing and elevated toxin production as its activated form binds to both P2 and
P3 promoters to drive the agr regulon and decrease repressor of toxin (rot), respectively.
However, deletion of agrB would theoretically only attenuate secretion of the quorum
signal peptide auto-inducing peptide 2 (AIP-2) (30-32). During monoculture, this would
disrupt sensing of the quorum signal via AgrC and negatively impact toxin production.
However, if C. albicans produced a molecule(s) that could be sensed by AgrC then the
native regulatory circuit could be bypassed during co-culture, resulting in elevated toxin
expression. Therefore, similar co-culture assays were conducted as in Figure 3-1, this
time including isogenic ΔagrA and ΔagrB mutants. As predicted, disruption of agrA led
to nearly a complete loss of hemolysis on Sheep’s blood (Figure 3-2A) and significantly
reduced levels of ⍺-toxin (Figure 3-2B). Moreover, deletion of agrB demonstrated
similar toxin phenotypes as compared to the ΔagrA mutant (Figure 3-2A, B). These
results suggested that an intact agr regulon is required for elevated toxin expression.
However, the augmented toxin phenotype was unlikely mediated by a fungal ligandbacterial receptor interaction governed through AgrC sensing.

A Role for Extracellular pH in Modulating agr Signaling During Coculture
Previous reports have determined that regulation of agr is influenced by a number
of physiologic factors, including low extracellular pH (115, 123). Therefore, we assessed
the pH of mono- and co-cultures following standard growth conditions. The pH of
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Figure 3-1. C. albicans enhances S. aureus ⍺-toxin production.
(A) Hemolytic activity of monomicrobial C. albicans (CA, blue), S. aureus (SA, yellow)
and polymicrobial cultures (CA+SA, green) was functionally assessed by depositing 20
μL of cell-free culture supernatants into wells on a Sheep’s blood agar plate. Images were
taken after incubation at 37°C for 24 h using a digital scanner. (B) A P3-GFP reporter
strain of S. aureus was incubated alone or with C. albicans. After 16 h of growth, 100 μL
culture was removed in triplicate, added to a 96-well plate, and the fluorescence
measured at 488/515 nm on a fluorimeter. (C) Concentration of ⍺-toxin in supernatants
from monomicrobial and polymicrobial cultures was measured by ELISA. Data is
representative of 3 independent repeats and expressed as the mean ± SEM. Data was
assessed for significance using one-way ANOVA and Dunnett’s posttest. **, P < 0.01;
***, P < 0.001.
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Figure 3-2. Candida-enhanced toxin production is dependent on intact
staphylococcal agrA and agrB signaling.
(A) Hemolytic activity of polymicrobial cultures of C. albicans (CA) with wild-type S.
aureus (SA) or isogenic strains lacking agr genes (ΔagrA or ΔagrB) was functionally
assessed by depositing 20 μL of cell-free culture supernatants into wells on a Sheep’s
blood agar plate. Images were taken after incubation at 37°C for 24 h using a digital
scanner. (B) Levels of ⍺-toxin were measured in polymicrobial culture supernatants by
ELISA. Data are representative of 3 independent repeats and expressed as the mean ±
SEM. Data was assessed for significance using one-way ANOVA and Dunnett’s posttest.
*, P < 0.05.
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C. albicans monoculture was estimated to be ~7.5 ± 0.1, while that of S. aureus
monoculture was ~5.2 ± 0.2 (Figure 3-3A). Interestingly, the pH of the co-culture was
~6.7 ± 0.2 (Figure 3-3A). The pH of fresh TSB-g was determined to be 7.2 ± 0.2.
Therefore, it appeared as though C. albicans was elevating or maintaining the pH in a
range which is optimal for agr activation. We next determined whether enhanced agr
activity during co-culture could be overridden by experimental modulation of the pH via
buffering TSB-g with 100 mM MOPS. We specifically chose to assess pH points that
closely matched to those representing C. albicans mono, S. aureus mono, and co-culture
values. Similar to previous results, use of the P3-GFP reporter system indicated induction
of agr signaling in unbuffered medium (Figure 3-3B). However, when the pH was
buffered to acidic conditions (pH 5.5), agr signaling was significantly attenuated (Figure
3-3B). When the pH was set to the agr optimum (pH 6.5), much higher levels of agr
signaling were observed; however, differences between mono and co-culture were no
longer distinguishable (Figure 3-3B). Similar results were found at a slightly more
alkaline pH (7.5), where agr signaling between mono and co-cultures was indiscernible
(Figure 3-3B). These results suggest that extracellular pH strongly influences agr
signaling in vitro and likely drives augmentation of toxin production during co-culture.
In order to rule out the possibility that growth rates between different pH
conditions were impacting agr reporter results, aliquots of each culture were taken at the
experimental endpoint and plated onto selective microbiological media to enumerate both
C. albicans and S. aureus. Although there was slight variation between each condition,
there was no significant difference in the number of colonies of C. albicans
(Figure 3-3C, blue) recovered during mono- (solid) and co-culture (hashed). Moreover,
there was no significant difference between growth in buffered or unbuffered media. The
same finding was true for S. aureus (Figure 3-3C, yellow) during mono (solid) and coculture (hashed). Collectively, these results suggest that extracellular pH and not
microbial growth accounts for disparate agr activity observed during mono and coculture.
In order to rule out the possibility that a factor secreted by C. albicans activates
agr signaling, S. aureus(pDB22) was grown at pH 5.5 overnight to attenuate agr
signaling. Spent culture supernatants from C. albicans or S. aureus (JE2) grown at pH 7
were filter sterilized, reconstituted in fresh concentrated growth medium, and added to S.
aureus(pDB22) to elicit agr activation. Fresh culture medium was also used as a control.
Results demonstrated that while spent culture medium from S. aureus (JE2) more rapidly
and robustly activated the agr system, addition of spent C. albicans supernatant did not
differ from the fresh culture medium, suggesting that culture pH and not a specific
candidal factor drives quorum signaling (Figure 3-3D).
Several recent reports have demonstrated that C. albicans possesses the incredible
capacity to rapidly alkalinize its external environment via amino acid catabolism (124,
126, 127). This process is primarily driven during carbohydrate stress by sensing of
amino acids in the milieu and regulating amino acid import, largely governed by the
transcription factor Stp2p. Ammonia is extruded from the cell as these peptide substrates
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Figure 3-3. Synergistic hemolysis is partially dependent on extracellular pH and
can be overridden by its modulation.
(A) The pH of monomicrobial (CA or SA) and polymicrobial (CA+SA) cultures was
measured after 16 h incubation at 37°C. (B) Assays were conducted similarly as in panel
A, except that the pH of TSB-g was buffered as indicated. Activation of staphylococcal
agr was assessed using a GFP-reporter assay. (C) Aliquots from each culture were taken
at the endpoint to measure microbial counts by plating on selective media. Blue bars
indicate C. albicans counts and yellow bars indicate S. aureus counts. Solid bars depict
counts from monomicrobial (mono) cultures, while hashed bars depict counts from
polymicrobial (poly) cultures. (D) Buffered (pH 7.0) spent CA and SA culture
supernatants or fresh media were added to S. aureus(pDB22) initially grown at pH 5.5.
Fluorescence (488 nm) was captured kinetically to assess agr activation. All data is
representative of 3 independent repeats and expressed as the mean ± SEM. Data was
assessed for significance using one-way ANOVA and Dunnett’s posttest. **, P < 0.01;
***, P < 0.001.
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are consumed by the fungus, ultimately raising the extracellular pH (68, 128). Therefore,
we utilized an stp2Δ/Δ mutant and isogenic revertant strain (stp2Δ/Δ+STP2) to determine
the impact of alkalinization during co-culture with S. aureus. Culture pH of the stp2Δ/Δ
during co-culture was significantly decreased as compared to that of wild-type or
revertant strains (Figure 3-4A). In a similar fashion, production of ⍺-toxin was
significantly attenuated during co-culture with the stp2Δ/Δ strain (Figure 3-4B). Thus,
active alkalinization of the external environment by C. albicans partially modulates
staphylococcal ⍺-toxin production during co-culture.
Candida Species Differentially Modulate ⍺-Toxin Production During Coculture
We next questioned whether augmented ⍺-toxin production was specific to C.
albicans or if other non-albicans Candida (NAC) species could also potentiate this effect.
Therefore, S. aureus was cultivated by itself or in the presence of various Candida
species, including C. albicans, C. glabrata, C. dubliniensis, C. tropicalis, C. parapsilosis,
and C. krusei. Measurement of the extracellular pH following co-culture with C.
albicans, C. tropicalis, and C. krusei revealed significantly increased neutralization over
S. aureus monoculture (Figure 3-5A). Co-culture with C. glabrata, C. dubliniensis, and
C. parapsilosis demonstrated only modest increases in pH which were generally below
the threshold for robust agr activation. These results were recapitulated by examining ⍺toxin production during co-culture. Candida species capable of significantly raising the
extracellular pH in this assay (C. albicans, C. tropicalis, C. krusei) also demonstrated
increased capacity to augment ⍺-toxin release, while those incapable of significantly
modulating the extracellular pH demonstrated only modest elevation of this virulence
determinant (Figure 3-5B). These results demonstrate that exacerbation of ⍺-toxin
production is not limited to C. albicans, but this in vitro phenotype is largely driven by
modulation of extracellular pH during co-culture.

Conclusions
Often, the pathogenic process is delineated as the interaction between host and
microbe resulting in some level of host detriment. Unfortunately, the contribution of
microenvironment is all too frequently disregarded in this description. However, changes
in environmental factors can ultimately drive or control pathogenicity or host
susceptibility. Through the prism of single microbe infections, this concept seems
obvious. For example, gene expression exhibited by C. albicans is very different in the
gut as compared to in the oral cavity-largely attributable to variations in host cell type,
oxygen tension, nutrient availability, and microbial competition (7, 68, 129). In the
context of a polymicrobial model of disease, gene regulation in response to environment
by one organism may elicit reactions by a second pathogen, opportunist, or colonizer. An
excellent example of this is the capacity of the lactobacilli to ferment carbohydrates to
lactic acid at the vaginal mucosa (130). Production of relatively high levels of lactic acid
keeps the vaginal pH low and consequently impairs the overgrowth of C. albicans,
limiting the development of vulvovaginal candidiasis. While there are several examples
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Figure 3-4. The alkalinization-deficient C. albicans mutant stp2Δ/Δ fails to
enhance S. aureus toxin production.
Polymicrobial cultures of S. aureus and wild-type C. albicans (CA + SA), SA and STP2
mutant (stp2Δ/Δ + SA), or SA and STP2 revertant (stp2Δ/Δ+STP2 + SA) were incubated
at 37°C in media initially set to pH 6. At 24 h, (A) the pH of the cultures was measured
using a pH meter and (B) ⍺-toxin levels in supernatants were determined by ELISA. (C)
Aliquots from each culture were taken at the endpoint to measure microbial counts by
plating on selective media. Blue bars indicate C. albicans counts, and yellow bars
indicate S. aureus counts. Solid color bars depict counts from monomicrobial (mono)
cultures, while hashed bars depict counts from polymicrobial (poly) cultures. Data are
representative of 3 independent repeats and expressed as the mean ± SEM. Data was
assessed for significance using one-way ANOVA and Dunnett’s posttest. *, P < 0.05; **,
P < 0.01.
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Figure 3-5. Candida spp. differ in their capacity to modulate extracellular pH and
augment toxin production during polymicrobial growth with S. aureus.
Polymicrobial cultures of Candida species [C. albicans (CA), C. glabrata (CG), C.
dubliniensis (CD), C. tropicalis (CT), C. parapsilosis (CP), C. krusei (CK)] and S. aureus
(SA) were incubated at 37°C. After 16 hours of growth, (A) the pH of the cultures was
measured using a standard pH meter and (B) the level of ⍺-toxin in the supernatant was
assessed by ELISA. Data is representative of 5 independent repeats and expressed as the
mean ± SEM. Data was assessed for significance using one-way ANOVA and Dunnett’s
posttest. **, P < 0.01; ***, P < 0.001.
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of “environmental crosstalk” resulting in microbial antagonism, reports regarding
exacerbated virulence are less common (8, 17, 19, 20).
We, along with others, have previously shown that murine intra-abdominal coinfection with C. albicans and S. aureus results in a strikingly high mortality rate (~90%)
within ~16 h p.i., while infection with either microbe alone is non-lethal (65). Moreover,
this synergistic lethality is dependent on ⍺-toxin, as an isogenic strain lacking the gene
encoding for this virulence factor (hla) or neutralization of this toxin using a high affinity
antibody resulted in significant protection. In support of this, lavage of the peritoneal
cavity following infection revealed ~4-fold higher levels of ⍺-toxin in co-infected mice as
compared to those challenged with S. aureus alone (65). These in vivo results
substantially mimic those observed in the in vitro system used in this study. Using several
functional assays, we confirmed that α-toxin levels are significantly elevated during
polymicrobial as compared to monomicrobial growth in an agr-dependent fashion.
Interestingly, the mechanism of ⍺-toxin enhancement was not likely due to direct fungal
ligand binding or recognition by the agr quorum sensing system, as S. aureus mutants
with disrupted agr genes (ΔagrA or ΔagrB) failed to demonstrate toxin production even
during co-culture with C. albicans, indicating necessity of an intact agr regulon (Figure
3-2). There are numerous examples where secreted microbial peptides or metabolites can
exhibit a diverse array of effects on neighboring cells of the same or different species (17,
19, 131). Deletion of agrB, the auto-inducing peptide permease, should still allow for
functional agr signaling in the context of candidal factors capable of inducing the AgrCAgrA two-component system. Observed failure to activate toxigenic and agr responses
under such conditions or with spent C. albicans culture supernatant likely indicates that
potential fungal ligands do not directly signal via the AgrC surface receptor.
The exclusion of a factor directly engaging agr led us to investigate potential
indirect influences, such as modulation of environmental factors. In pioneering work
characterizing the agr quorum sensing system in S. aureus, Regassa et al. demonstrated
the pH-responsiveness of the agr system. They reported increased agr activity during
growth at pH 6.5-7 as compared to growth in more alkaline or acidic media (115, 123).
The pH of monomicrobial S. aureus cultures demonstrated significant acidification (pH
5.0-5.5), while co-cultures exhibited a pH of 6.5-7, exactly in the range of maximum agr
activity (Figure 3-3A). Buffering of the media demonstrated that agr signaling could be
manipulated positively or negatively during co-culture depending on pH selection, further
demonstrating the importance of environmental factors (e.g. pH) in driving pathogenicity
mechanisms in vitro. Both C. albicans and S. aureus preferentially utilize glucose to
undergo oxidative and fermentative metabolism, ultimately producing acidic endproducts that drive lower culture pH. So then why does the culture medium containing C.
albicans demonstrate an elevated pH? The ability of C. albicans (and other fungal
species) to alkalinize its environment has been well documented in the literature.
Vylkova et al. have demonstrated that C. albicans can raise the pH of macrophage
phagosomes, allowing for hyphal growth that damages the phagosomal membrane, aiding
in escape and continued proliferation (124, 126). Moreover, the acidic pH (≤5) of the
phagosome is vital for the activity of degradative enzymes that act to kill and digest
engulfed pathogens, including fungi. Additionally, low pH is known to repress the
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morphological transition of yeast-to-hyphae, the major virulence attribute of C. albicans
(33). Therefore, C. albicans has evolved strategies to modulate the external pH to likely
bypass host checkpoints and killing mechanisms.
We propose that during polymicrobial growth, the pH initially decreases as
glucose is metabolized by both organisms, then when glucose is limiting, the culture
medium is alkalinized by C. albicans, in turn activating the agr quorum sensing system
and subsequent ⍺-toxin production. The mechanism of alkalinization involves the
breakdown of amino acids for a carbon source and the subsequent excretion of ammonia,
which raises the pH. In glucose-limited environments, amino acids are sensed by the SPS
sensor system, a complex of three proteins (Ssy1, Ptr3, and Ssy5). This sensor complex
induces the proteolytic cleavage of a cytoplasmic retention signal of Stp2p, allowing it to
translocate to the nucleus. Stp2p binds SPS sensor-regulated promoters of various amino
acid permease genes, including CAN1, GAP1, and GAP2, which transport extracellular
amino acids into the cell (132). Amino acid catabolism begins with the deamination of an
amino acid, catalyzed by amino acid-specific deaminases. The carbon backbone is
converted to TCA cycle intermediates (pyruvate, α-ketoglutarate, acetoacetyl-CoA) via
the production of acetyl-CoA. The nitrogen is converted to ammonia and CO2 by the urea
amidolyase Dur1,2p, and subsequently excreted from the cell through various ATO
(ammonia transport outward) family transmembrane proteins (127, 128, 132). C. albicans
strains lacking STP2 have an impaired capacity to alkalinize the environment compared
to isogenic controls, corresponding with a decrease in ammonia produced during growth.
Additionally, this mutant is unable to form hyphae after phagocytosis, preventing escape
from the phagosome, which also leads to more effective killing by the macrophage. In a
mouse model of disseminated candidiasis, stp2Δ/Δ mutants displayed attenuated
virulence, as mortality was significantly delayed compared to wild-type or complemented
strains (124). Using a stp2Δ/Δ strain in our in vitro polymicrobial culture system, we
found that the mutant cannot raise the pH to levels observed with wild-type or the
revertant strains. This further confirms that the capacity of C. albicans to alkalinize the
media contributes to enhanced ⍺-toxin production during co-culture (Figure 3-4).
Although Stp2p is largely responsible for driving the alkalinization phenotype in
C. albicans, it is not the sole mechanism for pH modulation. A number of C. albicans
genes have been identified as having effects on external alkalinization, including ALI1,
SIN3, COX4, PEP8, KIS1, and CPH1. Some of these genes (COX4 and KIS1) are linked
to carbon metabolism, while CPH1 can regulate galactose utilization. C. albicans has
also been shown to modulate pH without the production and excretion of ammonia, as
seen during growth with non-fermentable carbon sources, like the carboxylic acids αketoglutarate, pyruvate, and lactate (128, 132). Interestingly, alkalinization occurs in low
glucose environments, regardless of the mechanism, indicating that this effect is glucose
repressible. Vylkova et al. hypothesize that alkalinization of the phagosome is due to
limited glucose within the phagosomal compartment (124). Although glucose or other
metabolic compounds were not a direct focus of this paper, their potential effect on pH
and α-toxin production can be inferred. In addition to being responsive to pH, the agr
quorum sensing system is known to be regulated by glucose levels, with growth under
high glucose conditions correlated to low agr activity. Future studies focusing on the
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metabolic profiles of both C. albicans and S. aureus may shed more light on this potential
effector mechanism.
Lastly, we investigated the ability of other NAC species to enhance α-toxin
production during in vitro growth. We found that the species differ in their alkalinization
potential, with only C. tropicalis and C. krusei able to raise the pH of the media to levels
similar to that of C. albicans during polymicrobial growth with S. aureus. Additionally,
these three species were the only ones that caused a significant increase in the amount of
α-toxin produced, compared to S. aureus monomicrobial culture (Figure 3-5). These data
correlate nicely with work performed by Nash et al. in which mice were co-infected with
the exact same Candida strains. Mortality was observed in mice infected with S. aureus
and C. albicans, C. tropicalis, and C. krusei. Strikingly, the species unable to modulate
the pH and α-toxin production during in vitro growth in this study (C. glabrata, C.
dubliniensis, and C. parapsilosis) were also non-lethal in the polymicrobial IAI model
(67). A retrospective analysis of intra-abdominal infections, specifically looking at
candidiasis, revealed that C. albicans is the most commonly isolated species (50-75%).
The next most commonly isolated species is C. glabrata (12-25%), followed by C.
parapsilosis (3-10%), C. tropicalis (3-5%), and C. krusei (3-6%) (133, 134).
Interestingly, C. glabrata was implicated as the infectious organism in the majority
(64%) of recurrent or persistent infections (133). Cheng et al. described persistent C.
glabrata IAI in mice and an association with the formation of abscesses (68).
Various niches within the body are maintained at drastically different pH values.
For example, the oral cavity is maintained at pH 6.2 - 7.6 by saliva (135). The blood is
very tightly buffered to remain at pH 7.4, and a decrease in 0.05 units causes severe
physiological problems, as seen in diabetic ketoacidosis (136). The vagina is more acidic,
with a healthy pH ranging from 3.8 - 4.5 (137). The fluid within the peritoneal cavity of
humans is reported to be at a pH of 7.5 - 8 (138). Although widely variable, bodily pH is
tightly regulated to maintain homeostasis and dysregulation is often indicative of poor
health. A study investigating the transcriptome of C. albicans during murine IAI found
that a number of genes involved in pH response were among the most highly upregulated.
These genes include RIM101, the alkaline pH-regulated transcription factor that
modulates morphology and gene expression (68). Indeed, a rim101Δ/Δ strain exhibited
attenuated virulence during peritoneal infection, characterized by significantly lower
fungal burdens (68). These findings indicate that the murine peritoneal cavity is alkaline
and that C. albicans requires adaptation to pH to establish pathogenicity in this biological
niche. However, because of the homeostatic nature of pH maintenance, it is unlikely that
that C. albicans is able to drastically alter the global pH of the peritoneal cavity during
IAI. Our attempts to experimentally monitor broad pH changes in the peritoneal lavage
fluid during mono- or co-infection have demonstrated insignificant differences, partially
due to sensitivity of the techniques utilized (e.g. phenol red lavage, micro pH electrode)
or spatiotemporal kinetics. Thus, it is more likely that microenvironmental pH regulation,
in peritoneal abscesses or tissues, may play an important role in driving these phenotypes.
As C. albicans and S. aureus are known to tightly associate via staphylococcal binding of
fungal hyphae via the candidal adhesin Als3p (50), it is possible that elevated S. aureus
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α-toxin production in vivo is due to local pH changes surrounding fungal-bacterial
aggregates. However, this hypothesis requires future investigation.
Collectively, results from this study highlight the dynamic and complex nature of
this fascinating microbial pair and polymicrobial interactions in general. Furthermore,
they underscore the importance of environmental adaptation and its intersection with
virulence that must be considered in the context of co-infection.
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CHAPTER 4. A CRITICAL ROLE FOR THE CANDIDA ALBICANS
TRANSCRIPTION FACTOR, ZCF13, IN ENHANCING STAPHYLOCOCCUS
AUREUS ⍺-TOXIN PRODUCTION

Introduction
Candida albicans, an opportunistic fungus, and Staphylococcus aureus, a
ubiquitous bacterial pathogen, are among the top causes of serious nosocomial infections
and invasive diseases (73, 74). While these microbes are able to cause significant
morbidity and mortality on their own, they are often co-isolated from various niches and
are correlated with more severe disease states and higher mortality rates, even with
therapeutic intervention (42, 44, 56, 57, 120, 139). Intra-abdominal infections (IAI),
which are a collection of diseases characterized by microbial invasion into and
inflammation of the abdominal cavity, are often polymicrobial (133). The introduction of
microbes generally results from trauma, such as perforations to the gastrointestinal tract,
invasive surgery, and contamination of indwelling catheters. IAI can lead to more
complicated infections, like sepsis, and are the second-most common cause of infectious
mortality in ICU patients (55). Fungal-bacterial polymicrobial IAI result in more severe
disease and increased mortality, up to 80%, compared to 10-30% mortality in bacterial
IAI (56, 57). Additionally, C. albicans has been identified as an independent risk factor
for mortality during IAI (140).
In support of this clinical data, a mouse model of polymicrobial IAI using C.
albicans and S. aureus revealed a striking lethal synergism, where co-inoculation rapidly
resulted in 100% mortality, while monomicrobial infections were non-lethal (59). S.
aureus produces a number of toxins, primarily regulated through the agr quorum sensing
system (32). Previous work from our laboratory has demonstrated that C. albicans is able
to augment S. aureus agr activity and upregulate agr-associated genes during
polymicrobial growth, most notably that responsible for ⍺-toxin production (65).
Encoded by the hla gene, ⍺-toxin is a small hemolytic exotoxin that is secreted as a
monomer which oligomerizes into a heptameric β-barrel and is capable of nonspecifically forming pores in many different cell types, including red blood cells,
epithelial cells, endothelial cells, and various immune cells. It is also recognized by a
disintegrin and metalloproteinase domain-containing protein 10 (ADAM10) receptor in
the membrane with high affinity (30). Upon binding to ADAM10, ⍺-toxin inserts its stem
domain into the membrane, forming a pore through which cations and low molecular
weight molecules can flow, leading to cell lysis. However, ⍺-toxin can also interact with
cells in a receptor-independent manner at high concentrations by binding to host
membrane lipids, thus causing lysis without specific binding to ADAM-10 (141).
Subsequent cytolysis disrupts endothelial junctions and initiates pro-inflammatory
immune responses by activating multiple signaling cascades, including the NLRP3
inflammasome (30). We have previously shown that inflammatory markers, such
prostaglandin PGE2 and the proinflammatory cytokines IL-6, IL-1β, and TNF-⍺, are
significantly upregulated in the peritoneum of C. albicans-S. aureus infected mice (62,
65, 66). In addition, ⍺-toxin mediates platelet aggregation, leading to excessive
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microvascular clotting and thrombocytopenia observed in staphylococcal sepsis.
Dysregulation of thrombosis can lead to significant host organ damage that contributes to
the pathogenesis of sepsis. ⍺-toxin has been shown to directly damage both the liver and
kidneys through the induction of thrombotic events (58, 142).
While it has been established that C. albicans is able to enhance staphylococcal ⍺toxin production in vitro and in vivo, the mechanism(s) by which C. albicans achieves
this are incompletely defined (65). We have previously determined that there is not likely
a candidal secreted factor that is directly stimulating the AgrC receptor of S. aureus to
enhance ⍺-toxin production (122). However, we found that extracellular alkalinization by
C. albicans plays an important role in modulating agr signaling. The agr system is
responsive to pH, and during co-culture C. albicans raises the pH to optimal levels for
agr activity. Additionally, an alkalinization-deficient mutant (Δ/Δstp2) is unable to
enhance agr activity and ⍺-toxin production in vitro (122). However, this mutant showed
no pathogenicity defect during co-infection in the mouse model of IAI, and additional
genetically encoded or physiological stimuli must be required for synergistic lethality
(Figure 4-1).
Thus, the objective of this study was to further clarify the mechanism driving
synergistic lethality during C. albicans-S. aureus polymicrobial IAI by identifying novel
regulators of Candida-induced agr activation. In support of this, we show that
staphylococcal ⍺-toxin is necessary for exacerbated damage to the liver and kidneys
during co-infection and that an uncharacterized candidal transcription factor, ZCF13, is
required for augmenting these effector responses and ⍺-toxin production.

Materials and Methods

Ethics Statement
The animals used in this study were housed in AAALAC-approved facilities
located at the University of Tennessee Health Sciences Center (UTHSC) in the Regional
Biocontainment Laboratory (RBL). The UTHSC Animal Care and Use Committee,
Laboratory Animal Care Unit (LACU) approved all animal usage and protocols (protocol
#18-060). Mice were given standard rodent chow and water ad libitum. Mice were
monitored daily for signs of distress, including noticeable weight loss and lethargy.
UTHSC LACU uses the Public Health Policy on Humane Care and Use of Laboratory
Animals (PHS) and the Guide for the Care and Use of Laboratory Animals as a basis for
establishing and maintaining an institutional program for activities involving animals. To
ensure high standards for animal welfare, UTHSC LACU remains compliant with all
applicable provisions of the Animal Welfare Act (AWAR), guidance from the Office of
Laboratory Animal Welfare (OLAW), and the American Veterinary Medical Association
Guidelines on Euthanasia.
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Figure 4-1. An alkalinization-deficient mutant shows no defect in synergistic
lethality in polymicrobial IAI.
Mice (n = 8 per group) were infected with SA and either C. albicans SC5314, stp2Δ/Δ, or
stp2Δ/Δ+STP2 and followed for survival. Experiments were repeated twice and data
combined. Significance was assessed using a Wilcoxon log rank test.
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Strains and Growth Conditions
Candida albicans strain SC5314 (CA) was used as the wild-type/reference strain
for all experiments unless otherwise noted. The alkalinization-deficient mutant stp2/
(SVC17) and its isogenic revertant strain STP2-REV (SVC19) were kind gifts from Dr.
Michael Lorenz (University of Texas Health Science Center) (124). A library of C.
albicans transcription factor deletion mutants and accompanying wild-type background
strain (TF WT) were obtained from the Fungal Genetics Stock Center (143). Strains were
maintained in glycerol stocks in 96-well plates and stored at -80°C. S. aureus strain JE2
(SA) (a USA300 isolate used as wild-type) and strain NE1354 (Δhla) (⍺-toxin-deficient)
were obtained from the Biodefence and Emerging Infectious (BEI) Research Resources
repository (89). A S. aureus reporter strain [S. aureus(pDB22)] (containing plasmid
pDB22 with the P3 promoter fused to GFPmut2 and erythromycin resistance cassette) was
also used in this work, as described previously (125).
Candida strains were streaked onto yeast peptone dextrose (YPD) agar plates and
grown at 30°C. Single colonies were inoculated into 1.5 mL YPD broth and grown at
30°C with shaking at 200 rpm. S. aureus strains were streaked onto trypticase soy agar
(TSA) (with antibiotic added as needed) and grown at 37°C. Single colonies were
inoculated into 1.5 mL TSB (with antibiotic added as needed) and grown at 37°C with
shaking at 200 rpm. Escherichia coli strains DH5-⍺ and IM08B (obtained through BEI
Resources) were used for plasmid construction and were grown on Luria-Bertani (LB)
agar supplemented with 100 μg/mL ampicillin or 50 μg/mL kanamycin as described (91,
144).

Murine Model of IAI
I.p. inoculations were conducted as described previously (62, 65-67). Groups
(n = 4) of six-to-eight-week old Swiss Webster mice were injected intraperitoneally (i.p.)
using a 27-gauge ½” needle with 1.75 x 107 or 7 x 106 CFU of C. albicans, 8 x 107 CFU
of S. aureus, or the above doses of each microbe simultaneously. Inocula were prepared
in a final volume of 0.2 mL pyrogen-free phosphate buffered saline (PBS). After
inoculation mice were observed up to 5 d p.i. for morbidity (hunched posture, inactivity,
ruffled fur) and mortality. Mice that exhibited severe morbidity were humanely sacrificed
and tallied as a lethal outcome.
In some experiments, mice were sacrificed 8 h p.i. prior to severe morbidity.
Peritoneal cavities were lavaged by injection of 2 mL of sterile PBS containing 1X
protease inhibitors (cOmplete, Roche) followed by gentle massaging of the peritoneal
cavity. Peritoneal lavage fluid was then removed using a pipette inserted into a small
incision in the abdominal cavity. Both kidneys and the spleen were removed from
infected mice and placed in 500 μL PBS for homogenization prior to CFU enumeration
and ELISA analysis. Whole blood was collected by cardiac puncture and serum was
separated by centrifugation. Animal experiments were repeated in duplicate and results
combined.
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Clinical Chemistry Analysis
Clinical chemistry analysis of serum was performed using a DiaSys Respons®
910Vet chemistry analyzer (DiaSys Diagnostic Systems, USA. Wixon, MI). All tests
were calibrated (TruCalU calibrator, DiaSys Diagnostic System) and bi-level quality
control materials (TruLab N and TruLab P, DiaSys Diagnostic Systems) run prior to
sample analysis. The Respons 910Vet chemistry analyzer uses colorimetry with either a
rate or end point reaction method. All reagents were purchased from DiaSys and analysis
performed by RBL staff according to manufacturer’s established procedures.

Site-Directed Mutagenesis
Construction of the oligomerization-deficient H35L ⍺-toxin mutant was done
using Platinum SuperFi I (ThermoFisher) following the manufacturer’s site-directed
mutagenesis protocol. Primers H35L-Superfi-F and H35L-Superfi-R were used to PCR
amplify pSK-hla (vector pSK5630 containing the entire hla ORF from S. aureus JE2
(Table 4-1) (122). Amplified DNA was digested with DpnI to remove residual template
DNA and transformed into the dcm-deficient E. coli strain IM08B to yield plasmid pSKH35L. pSK-H35L was electroporated into S. aureus NE1345 Δhla and selected on TSA
with 10 μg/mL chloramphenicol to create strain Δhla-phla-H35L. To confirm correct
mutagenesis, plasmid isolated from colonies underwent Sanger sequencing using primers
hlaSeqF and hlaSeqR.

Construction of Luciferase Reporter
To construct a P3-luciferase reporter plasmid, the S. aureus P3 promoter was PCR
amplified from a gBlock containing the P3 promoter and flanking amplification and
restriction sequences (Table 4-2). This PCR product and plasmid pMV306G13+Lux
(Addgene plasmid # 26160 ; http://n2t.net/addgene:26160 ; RRID:Addgene_26160)
containing the LuxABCDE operon were digested with NotI and NcoI, ligated, and
transformed into E.coli DH5-⍺ to yield pOLux1 using the method previously described
(65). The entire P3-LuxABCDE operon from pOLux1 was PCR amplified using primers
luxABCDE-Fv2-EcoRI and luxABCDE-R-NarI. This product, along with plasmid
pMK4, were digested with EcoRI and NarI. Digests were ligated and transformed into
E.coli DH5-⍺, yielding plasmid pOLux2. The constitutive S. aureus promoter sarA P1
was synthesized as a gBlock and, along with pOLux2, was digested with Acc65I, ligated,
and transformed into E.coli DH5-⍺, yielding pOLux3. Correct orientation of the sarA P1
promoter in pOLux3 was confirmed by PCR amplifying with primers sarAP1-FAcc65I
and luxC-DET-R. pOLux3 was transformed into E. coli IMO8B, as previously described
(65). After confirmatory digestion, plasmids were transformed into S. aureus JE2
competent cells and plated on brain heart infusion agar containing 10 μg/mL
chloramphenicol to yield strain S. aureus(pOLux). The P3 promoter drives expression of
the P. luminescens luciferase enzyme in an agr-dependent manner, and the constitutively
active sarA P1 promoter allows for constitutive expression of the substrate luciferin.
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Table 4-1.

Oligonucleotides used in this work.

Primer Name
H35L-Superfi-F
H35L-Superfi-R
hlaSeqF
hlaSeqR
P3lux-F-NotI
P3Lux-R-NcoI
luxABCDE-Fv2EcoRI
luxABCDE-RNarI
sarAP1-F-Acc65I
sarAP1-R-Acc65I
luxC-DET-R
ZCF13-FF-KpnI
ZCF13-FR-ApaI
ZCF13-RF-NotI
ZCF13-RR-SacI
ZCF13-AMPFSmaI
ZCF13-AMPRNotI
ZCF13-FLPINTF
ZCF13-FLPINTR
ZCF13-DET-F
ZCF13-DET-R
ZCF13-SEQ1-F
ZCF13-SEQ2-F
ZCF13-SEQ3-F
ZCF13-SEQ4-F
ZCF13-SEQ5-F
Neut5homologyF
Nat1INTF
Neut5LAMPF

Sequence 5’→3’
ATGGCATGCTCAAAAAAGTATTTTATAG
TACTTTTTTGAGCATGCCATTTTCTTTATC
GATATGTCTCAACTGCAATATTCTAAATTGACATA
ACATCATTTCTGAAGTTATCGGC
TCAGCGGCCGCATTTTAACATAAAAAAATTTACAGTTAA
GAATAAAAAACGACTAG
TCACCATGGGATCTCTGTAATCTAGTTATATTAAAACAT
GCTAAAAGCAT
TCAGAATTCATTTTAACATAAAAAAATTTACAGTTAAGA
ATAAAAAACGACTAG
TCAGGCGCCGATCACCGCGGCCATGAT
TCAGGTACCCTGATATTTTTGACTAAACCAAATGC
TCAGGTACCGATGCATCTTGCTCGATACATTTG
GTCACGAATGTATGTCCTGC
TCAGGTACCAATCAAGCCTCCTGTACCACCACCA
TCAGGGCCCGCCTGGACTATTTGTCTTATCCATAATCGAT
TCAGCGGCCGCGTGATGAAATTTTGGATCCTGTTGCTTG
TCAGAGCTCGGCATGTTGTTGCTTTAGTGTCAGG
TCACCCGGGGACATCTCTCATTTGGTATAAATGATTGTC
GG
TCAGCGGCCGCGCTTTAGTGTCAGGTGTTAACACAACA
CAAGCCTCCTGTACCACCACCA
GCTTTAGTGTCAGGTGTTAACACAACACT
CCACAACTGCAACAATCACAACAT
CGATGATGGAGCTGTTTGATCAGAT
GTATCCCCCTCAACTAGCAGTTAG
CACCACCTTCTGTAACGACACCA
GCCAATTTCACTGATGCATTTGACATGA
CCGCACGTTTCAGAAGATCCC
GCCGCTAGTGATCAACTGTTTTTCC
GCAGATATGAGATAAAAGTTTTAAAGGACAAGAAAAGG
CCCAGATGCGAAGTTAAGTGCG
GCTGAATCACTTGATAGGATTTAGTTCCATTATGG

Point mutations in bold and italics. Restriction sites underlined.
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Table 4-2.

Sequences of gBlocks used in this work.

gBlock Name
Sequence 5’→3’
sarA P1
CGCAGTTACGGATCAGTCACGGTACCCTGATATTTTTGACTA
AACCAAATGCTAACCCAGAAATACAATCACTGTGTCTAATG
AATAATTTGTTTTATAAACACTTTTTTGTTTACTTCTCATTTTT
AATTAGTTATAATTAACTAAATAATAGAGCATTAAATATATT
TAATAAAACTTATTTAATGCAAAATTATGACTAACATATCTA
TAATAAATAAAGATTAGATATCAATATATTATCGGGCAAATG
TATCGAGCAAGATGCATCGGTACCAGCAAAGAACATGGCAG
CACC
agr P3
CGCAGTTACGGATCAGTCACGCGGCCGCATTTTAACATAAAA
AAATTTACAGTTAAGAATAAAAAACGACTAGTTAAGAAAAA
TTGGAAAATAAATGCTTTTAGCATGTTTTAATATAACTAGAT
TCCATGGAGCAAAGAACATGGCAGCACC
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IVIS Imaging
Groups of mice (n = 4) were infected as described above, with S. aureus(pOLux).
To minimize background interference, mice were given alfalfa-free rodent chow (Envigo)
for a week prior to infection and imaging. Bioluminescence imaging was performed with
Xenogen IVIS Spectrum. Mice were lightly anesthetized with isoflurane and imaged at 4
h intervals (145). Images are uniformly scaled and average counts within ROI were
determined with Living Image 4.7.3.

GFP and Luciferase agr Reporter Assays
Overnight cultures of C. albicans (YPD at 30°C) and S. aureus(pDB22) or S.
aureus(pOLux) (TSB at 37°C) were washed three times with phosphate-buffered saline
(PBS) by centrifugation. Cell concentrations were adjusted to 1 x 107 CFU/mL and
1:1000 dilutions were made into 5 mL of 0.6X TSB + 0.2% glucose (TSBg) for
monomicrobial (CA or SA) or polymicrobial (CA+SA) cultures. Antibiotic (10 μg/mL
erythromycin for pDB22, 10 μg/mL chloramphenicol for pOLux) was added for plasmid
maintenance. Cultures were incubated at 37°C with shaking at 200 rpm for 16 hours. 100
μL aliquots were removed in triplicate and added to wells of black (GFP) or white
(luciferase) 96-well microtiter plates. Fluorescence (488 nm excitation, 525 nm emission)
or luminescence (integration time 1 min) was measured using a Synergy H1 plate reader
(Biotek). Experiments were repeated in triplicate and are expressed as mean arbitrary
fluorescence units (AFU) or relative light units (RLU) ± standard error of the mean
(SEM).

Blood Agar Lysis Assay
Mono- and polymicrobial cultures were prepared as above. At 16 h postinoculation, 5 mL of culture was centrifuged at 5,000 rpm and resulting supernatant was
filter sterilized using a 0.2-µm syringe filter. Sterile supernatants were concentrated via
ethanol precipitation and resuspended in sterile water. Holes were made in blood agar
plates (TSA with 5% sheep’s blood) using a sterile pipette tip. Concentrated supernatants
were added to the wells and the plates were incubated at 37°C for 24 h. Plates were
imaged with a digital scanner (EPSON Perfection V700 Photo) and images are
representative of at least three independent repeats.

⍺-Toxin ELISA
The concentration of ⍺-toxin in culture supernatants or lavage and organ samples
was measured using an ⍺-toxin-specific sandwich ELISA, as described previously (65,
122). Briefly, 96-well microtiter plates were coated with 50 µL 0.1 µg/mL anti-⍺-toxin
antibody MEDI4893* diluted in ELISA/ELISPOT coating buffer (Invitrogen). Plates
were incubated at 4°C overnight. Plates were washed with PBS-Tween 20 (PBS-T) and
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blocked with SuperBlock (Pierce) for 1 h at room temperature. After washing with PBST, 50 µL filter-sterilized culture supernatants, peritoneal lavage fluid, or homogenized
organs were diluted in PBS, serially diluted, and plated along with native ⍺-toxin as the
standard. Plates were incubated for 1 h at room temperature and then washed with PBST. Affinity-purified rabbit polyclonal anti-⍺-toxin antibody (2 µg/mL) was added, and the
plate incubated for 1 h at room temperature. Plates were washed with PBS-T. AffiniPure
horseradish peroxidase (HRP)-coupled goat anti-rabbit IgG detection antibody (Jackson
ImmunoResearch) was diluted 1:10,000 added to wells and incubated for 1 h at room
temperature. After extensive washing with PBS-T, 100 µL 3,3’,5,5’Tetramethylbenzidine (TMB) substrate was added and plates were incubated in the dark
for 10 min. 100 µL of 0.2 M H2SO4 was immediately added to stop the reaction. Plates
were read at 450 nm using a plate reader (Synergy H1, BioTek). Experimental
concentrations were extrapolated to the standard curve. Culture supernatants or in vivo
samples from the S. aureus Δhla strain were blank subtracted to account for any
nonspecific antibody binding to shed protein A. Experiments were repeated in triplicate
(in vitro) or duplicate (in vivo) and data were combined and expressed as the mean ±
SEM.

CFU Enumeration
Microbial burdens of lavage fluid, homogenized kidneys and spleens of infected
mice, or culture media were determined as previously described. Briefly, serial dilutions
were plated onto YPD with 20 µg/mL nafcillin (for C. albicans enumeration) and TSA
with 2.5 µg/mL amphotericin B (for S. aureus enumeration) via the drop-plate method.
Plates were incubated overnight at 37°C. Microbial burden was enumerated and
expressed as CFU/mL. CFU values are representative of at least two independent repeats
and are represented as median ± SEM.

Transcription Factor Mutant Screen
C. albicans transcription factor mutants were screened for their ability to enhance
S. aureus agr activity following the GFP-agr reporter assay protocol. Since the
background and mutant strains are arginine auxotrophs, 40 mg/L arginine was
supplemented in the culture medium. Strains that were unable to significantly increase
GFP expression over that of a monomicrobial S. aureus culture were independently
confirmed and used for further analysis.

Plasmid Construction
Plasmids for ZCF13 gene disruption were constructed using plasmid pBSS2,
containing the SAT1-flipper disruption cassette (146). The 5’ flanking region of the
ZCF13 ORF was amplified from SC5314 genomic DNA using primers ZCF13-FF-KpnI
and ZCF13-FR-ApaI and ligated into pBSS2 at the KpnI and ApaI restriction sites to
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create pBSS2-ZCF13-F. The 3’ flanking region of the ZCF13 ORF was amplified from
SC5314 gDNA using primers ZCF13-RF-NotI and ZCF13-RR-SacI and ligated into
pBSS2-ZCF13-F at the NotI and SacI restriction sites to create pBSS2-ZCF13-FR.

ZCF13 Mutant Construction
Plasmid pBSS2-ZCF13-FR was digested with KpnI and SacI and the linear
fragment was transformed into SC5314 using a standard lithium acetate protocol with
some modifications (147, 148). Overnight cultures of SC5314 were diluted 1:200 in 5 mL
YPD and grown for 6 h at 30°C with shaking at 200 rpm and then washed by
centrifugation using sterile water. Cells were then resuspended in 1X TELiAc buffer (100
mM LiAc, 1X TE) and 50 µL of linearized pBSS2-ZCF13-FR was added to 50 µL cell
suspension. Single-stranded salmon sperm carrier DNA (5 µL) was added along with 300
µL 40% PEG. Transformation mix was incubated at 30°C for 30 min with agitation every
10 min. Cells were heat-shocked at 42°C for 15 min then allowed to recover in YPD at
30°C with shaking at 200 rpm for 4-6 h. Cells were pelleted and resuspended in 1X TE
and plated on YPD + 200 µg/mL nourseothricin (YPD+200NAT). Plates were incubated
for up to 2 days at 30°C. Colonies were grown overnight in 1 mL YPM (YP + 2%
maltose) to induce cassette excision. Cells from YPM cultures were washed with PBS
then diluted to 103 cells in 1X TE buffer. 100 µL cells was plated onto YPD + 25 µg/mL
nourseothricin (YPD+25NAT) and incubated at 30°C for 24 h. Small and medium-sized
colonies were patched onto YPD and YPD+200NAT and incubated at 30°C for 24 h.
Colonies that grew on YPD but not YPD+200NAT were confirmed by PCR to have
ZCF13 disrupted using primers ZCF13-FLPINT-F and ZCF13-FLPINT-R, ZCF13-DETF and ZCF13-DET-R.

ZCF13 Revertant Construction
One copy of ZCF13 was inserted into the neutral locus NEUT5L of Δ/Δzcf13
using the shuttle vector pDUP3. The entire ZCF13 ORF was PCR amplified from
SC5314 using primers ZCF13-AMPF-SmaI and ZCF13-AMPR-NotI. The PCR product
and plasmid pDUP3 were digested with SmaI and NotI and ligated to create pDUP3ZCF13. After transformation into DH5-⍺ and plasmid recovery, pDUP3-ZCF13 was
linearized by digesting with SfiI and then transformed into Δ/Δzcf13 following the
lithium acetate protocol described above. Revertant colonies were selected for by growth
on YPD+200NAT and confirmed by PCR using primers Nat1INTF and Neut5LAMPF,
Neut5homologyF and ZCF13-DET-R.

Statistical Analyses.
Gehan-Breslow-Wilcoxon and Wilcoxon log-rank tests were used to determine
the significance of mortality. Two-tailed, unpaired two-tailed, Mann-Whitney, and oneway ANOVA and Dunnett’s posttests were used to compare CFU and ⍺-toxin levels
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between groups, as indicated in figure legends. All graphs were constructed using
GraphPad Prism version 9. Figures were composed using MS PowerPoint and rendered
for publication with Adobe Photoshop.

Results
⍺-Toxin Is Responsible for Significant Organ Damage During Polymicrobial IAI
Based on prior reports of organ damage caused by ⍺-toxin in a model of
staphylococcal sepsis, we wished to determine whether ⍺-toxin contributed to the
significant morbidity and acute mortality observed during polymicrobial IAI (58, 142).
Mice were challenged intraperitoneally with C. albicans and S. aureus wild-type or an ⍺toxin-deficient mutant (Δhla) and biomarkers of organ damage kinetically assessed in the
serum. Polymicrobial infection with wild-type S. aureus led to significant increases in 3
common liver enzymes (alkaline phosphatase, ALP (Figure 4-2A); alanine transaminase,
ALT (Figure 4-2B); aspartate aminotransferase, AST (Figure 4-2C)) and an increase in
nitrogen blood levels (blood urea nitrogen, BUN (Figure 4-2D)) as compared to coinfection with the Δhla strain. Given that C. albicans augments ⍺-toxin production in
vivo, it is likely that increases in this potent virulence determinant leads to increased
damage to the liver and kidneys contributing to mortality.
⍺-Toxin Must Be Functional for Lethal Synergism
⍺-toxin is secreted as monomeric units but adopts a heptameric form in the cell
membrane which ultimately leads to pore formation (141, 149, 150). Key studies have
demonstrated that the H35 residue in the N-terminus is essential for stabilization of the
heptamer and amino acid changes at this residue abolishes lytic activity (151, 152).
Although mutated ⍺-toxin cannot form pores, it is still able to bind to ADAM10 in the
membrane and could potentially activate a number of intracellular signaling cascades to
drive pathogenicity. In order to determine whether toxigenic activity is required for
lethality during IAI, we constructed a plasmid containing the entire hla ORF (pSK-hla)
and used site-directed mutagenesis to introduce a single nucleotide change (182A<T)
leading to a nonsynonymous substitution in amino acid sequence (H35L). This plasmid
was named pSK-H35L. Plasmids pSK-hla and pSK-H35L were transformed into an ⍺toxin null mutant, Δhla. The hemolytic activity of the two complemented strains, Δhlaphla and Δhla-phla-H35L, was assessed by plating filter-sterilized supernatants from
overnight cultures in wells on blood agar. As expected, the supernatant from Δhla-phla
formed a zone of hemolysis, while the H35L mutant strain did not, despite similar ⍺toxin production (Figure 4-3A, B). Similar to prior reports, production of both ⍺-toxin
isoforms was increased when co-cultured with C. albicans (Figure 4-3B). In vitro growth
between these two complemented strains was not altered during in vitro mono- or
polymicrobial conditions (Figure 4-3C).
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Figure 4-2. Kinetic changes in organ damage biomarkers.
Mice (n = 8 per group) were infected with C. albicans (CA) + wild-type S. aureus (SA)
or an hla deletion mutant (∆hla) and sacrificed at 8, 10, or 12 h p.i. Levels of serum (A)
alkaline phosphatate (ALP), (B) alanine transaminase (ALT), and (C) aspartate
aminotransferase (AST) were measured as indicators of liver damage and (D) blood urea
nitrogen (BUN) levels were assessed. Significance was determined using an unpaired
multiple t-test. *, P < 0.05.
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Figure 4-3. ⍺-toxin activity is required for lethal synergism during polymicrobial
IAI.
(A) Filter-sterilized supernatants from S. aureus ∆hla-phla and ∆hla-phla-H35L cultures
were added to wells in blood agar plates and incubated at 37°C for 24 h. Plates were
scanned and images are representative of at least three independent repeats. (B) The
amount of ⍺-toxin in S. aureus ∆hla-phla (solid) and ∆hla-phla-H35L (hashed) ± C.
albicans (mono, yellow; poly, green) culture supernatants was measured via ELISA.
Experiment was repeated in triplicate and expressed as mean ± SEM. Significance was
determined by two-tailed Student’s t-test. *, P < 0.05; **, P < 0.01. (C) CFU levels (C.
albicans, blue; S. aureus strains, yellow) of monomicrobial and polymicrobial cultures at
16 h growth were assessed by microbiological plating on selective media. Counts were
assessed for significance using a Mann-Whitney U test. (D) Mice (n = 8 per group) were
infected with C. albicans (CA) and wild-type S. aureus (SA, black line), an hla-deficient
mutant (∆hla, red line), an hla-complemented strain (∆hla-phla, blue line) or the
oligomerization-deficient complemented strain (∆hla-phla-H35L, purple line) using
standard inocula. Survival was followed for up to 5 d p.i. Data are of two independent
repeats of 4 mice per group and combined. Significance was assessed by Gehan-BreslowWilcoxon test. ****, P < 0.001. (E) Microbial burdens were enumerated in the peritoneal
lavage fluid and homogenized spleen and kidneys by microbial plating on selective
media. Data is expressed as mean ± SEM. Significance was determined using an unpaired
two-tailed Student’s t-test. (F) Levels of ⍺-toxin found in the peritoneal lavage and
homogenized spleen and kidneys were measured by ELISA. Data is cumulative of two
independent repeats and expressed as mean ± SEM. Significance was determined by
Mann-Whitney test. Ns, non-significant.
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We next sought to determine whether the H35L mutant strain was able to induce
synergistic lethality during polymicrobial IAI with C. albicans. Mice were infected i.p.
with wild-type C. albicans and S. aureus JE2, Δhla, Δhla-phla, or Δhla-phla-H35L and
survival was followed for up to 5 d p.i. Mice infected with wild-type (JE2) S. aureus and
the wild-type hla-complemented strain succumbed to infection within 24 h p.i.,
whereas infection with the ⍺-toxin-null and H35L mutant was nonlethal (Figure 4-3D).
Notably, there were no significant differences in the amount of ⍺-toxin present or
bacterial burden in the kidneys, spleen, and peritoneal lavage fluid of mice infected with
the two complemented strains (Figure 4-3E, F). These data indicate that the
oligomerization and cytolytic activity of ⍺-toxin is required to drive lethality during
polymicrobial IAI.
Several C. albicans Transcription Factors Are Important for Enhancing S. aureus ⍺Toxin Production
While staphylococcal ⍺-toxin is necessary for lethality, the mechanism(s) by
which C. albicans augments its production both in vitro and in vivo remains undefined.
Despite the strong impact C. albicans-mediated alkalinization has on S. aureus agr
activity in vitro, an alkalinization-deficient mutant was still able to induce lethal
synergism during polymicrobial IAI (122) (Figure 4-1). In order to identify other
potential candidal factors involved in enhancing ⍺-toxin production, an unbiased screen
was undertaken. Mutants from a transcription factor deletion library were co-cultured
with an S. aureus agr reporter strain (S. aureus(pDB22)) (65, 122, 125, 143). Foldchange fluorescence of polymicrobial cultures was normalized to S. aureus(pDB22)
monoculture (Figure 4-4A). The TF WT control strain (indicated by pink dots) displayed
a consistent 2-2.5-fold increase in signal. We found 9 mutants in the initial screen that
failed to enhance agr activity (≥ 2 standard deviations of the mean, gray dotted lines) to
the same extent as TF WT. Follow-up assays confirmed that these mutants exhibited a
defect in augmenting agr activity (Figure 4-4B). These mutants are listed in Table 4-3.
The defect in agr activation of these mutants also extended to an inability to enhance ⍺toxin production (Figure 4-4C). CFU counts from polymicrobial cultures revealed that
Δ/Δbas1, Δ/Δleu3, and Δ/Δmsn4 had significant growth defects that likely explained their
inability to enhance agr activity; therefore, these mutants were excluded from further
analysis (Figure 4-4D). As the agr quorum sensing system is responsive to pH and
Candida-mediated alkalinization is a strong driver of agr activity in vitro, we determined
whether these mutants had alkalinization defects that could explain their inability to
augment agr activity (115, 122, 123). pH measurements demonstrated that Δ/Δsfl1,
Δ/Δgrf10, and Δ/Δisw2 exhibited significant alkalinization defects, which could be
attributing to the defective phenotype observed (Figure 4-4E).
We next evaluated the contribution of these 6 transcription factors in driving
synergistic lethality during polymicrobial IAI. Mice were infected with SA and either the
TF WT or deletion mutants and followed for survival (Figure 4-5A). Although the
majority of the mutants elicited normal lethality, Δ/Δsfl1 (red line) and Δ/Δzcf13 (green
line) had attenuated virulence (50 and 0% mortality, respectively). We evaluated the
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Figure 4-4. Screen of Candida transcription factor mutants reveals novel
regulators of S. aureus agr induction.
(A) TF WT (pink dots) or mutants (black dots) were grown with S. aureus(pDB22) in
polymicrobial cultures, fluorescence (488/515 nm) measured at 16 h, and plotted as foldfluorescence over S. aureus monomicrobial control. Mutants exhibiting altered
fluorescence changes are labeled in red (reduced) or green (enhanced). Dashed lines
represent 2 standard deviations from the population mean. Mutants identified in (A) were
confirmed for defect in (B) agr enhancement and (C) 𝛂-toxin production. (D) Growth of
Candida strains in polymicrobial culture was measured by plating of serial dilutions of
culture onto selective media. (E) The pH of polymicrobial cultures were measured at 16 h
p.i. All experiments were repeated in biological triplicate and represented as the mean ±
SEM. Significance was assessed using one-way ANOVA and Dunnett’s posttest. *, P <
0.05; **, P < 0.01; ****, P < 0.0001.
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Table 4-3.
C. albicans transcription factor mutants identified in screen to have
defects in augmenting S. aureus agr activity.
TF
ORF
#
001 19.454

Gene
Name
SFL1

006 19.2646

ZCF13

016 19.3809

BAS1

021 19.4000

GRF10

025 19.4225

LEU3

109 19.4752

MSN4

115 19.5908

TEC1

127 19.7401

ISW2

137 19.723

BCR1

Description/Function

References

Suppressor of flocculation; negative
regulator of morphogenesis,
flocculation; deletion and
overexpression results in attenuated
virulence.
Uncharacterized; predicted zinc-cluster
transcription factor; mutant has
decreased colonization of mouse
kidneys.
Regulator of purine biosynthetic genes;
mutants are adenine auxotrophs.
Involved in regulation of filamentation,
biofilm formation, adenylate
biosynthesis; null mutants exhibit
leaky adenine auxotrophy and
decreased filamentation; promoter
bound by BCR1, TEC1, EFG1,
NDT80, BRG1.
Predicted regulator of branched-chain
amino acid biosynthesis genes.
Uncharacterized zinc finger
transcription factor; not a significant
stress response regulator.
Hyphal gene regulator; regulates
BCR1; upregulated in alkaline
conditions; regulates pheromone
response of white cell phenotype;
regulated by Efg1p and Cph2p.
ATPase involved in chromatin
remodeling; required for
chlamydospore formation; mutants are
highly sensitive to fluconazole.
Required for formation of biofilms;
involved in hyphae formation;
regulated by TEC1; controls expression
of Als3p.

(153, 154)

Gene information acquired from the Candida Genome database (CGD):
http://www.candidagenome.org
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(155, 156)

(157, 158)
(157, 159)

(160, 161)
(162)

(163-165)

(166)

(158)

Figure 4-5. Δ/Δsfl1 and Δ/Δzcf13 mutants fail to cause synergistic lethality during
polymicrobial infection.
(A) Mice (n = 8 per group) were infected with SA and either TF WT or select previously
identified mutants (Δ/Δsfl1, Δ/Δzcf13, Δ/Δgrf10, Δ/Δtec1, Δ/Δisw2, Δ/Δbcr1) and
followed for survival. Experiments were repeated twice and data combined. Significance
was assessed using a Wilcoxon log rank test. (B) Microbial burdens in the peritoneal
lavage fluid and homogenized spleen and kidneys were enumerated by microbiological
plating at 8 h p.i. by selective microbiological plating. Line represents the median.
Significance was determined using Mann-Whitney test. (C) Levels of ⍺-toxin were also
assessed in the peritoneal lavage fluid and homogenized spleen and kidneys by ELISA.
Data is represented as mean ± SEM. Significance was determined using a one-way
ANOVA test. *, P < 0.05; **, P < 0.01.
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microbial burden in the kidneys, spleen, and peritoneal lavage fluid of mice infected with
TF WT, Δ/Δsfl1, or Δ/Δzcf13 with SA 8 h p.i. and found no significant differences in
colonization (Figure 4-5B). Despite similar growth, the Δ/Δzcf13 mutant was unable to
enhance S. aureus ⍺-toxin production in the kidneys, spleen, and peritoneal cavity to the
same level as the TF WT strain (Figure 4-5C). This data suggests that the transcription
factor ZCF13 is involved in modulating S. aureus virulence during polymicrobial IAI.

ZCF13 Is Necessary for Candida-Induced agr Activation
In order to confirm results obtained with the library deletion strain, independent
mutant (SC Δ/Δzcf13) and revertant (SC Δ/Δzcf13-Rev) strains were constructed in the
SC5314 background using the SAT1-flipper method (146). We confirmed that this
independent SC Δ/Δzcf13 mutant is deficient in enhancing agr activity and ⍺-toxin
during co-culture, with no observable differences during mono- or polymicrobial growth
(Figure 4-6A, B, C). Additionally, the ZCF13 revertant performed similarly to SC5314,
although we observed a modest, yet significant decrease in CFUs (Figure 4-6A, B, C).
We then co-infected mice with S. aureus and SC5314, SC Δ/Δzcf13, or SC Δ/Δzcf13-Rev
and followed survival for up to 6 d p.i. While SC Δ/Δzcf13 did induce some mortality, it
was significantly delayed and attenuated compared to wild-type and revertant
polymicrobial infection (Figure 4-6D). Importantly, we did not see any colonization
defects between the three strains in the kidneys, spleen, or peritoneal lavage fluid
(Figure 4-6E). However, SC Δ/Δzcf13 was unable to enhance ⍺-toxin production to the
same levels seen with SC5314 or SC Δ/Δzcf13-Rev (Figure 4-6F). This data indicates a
crucial role for ZCF13 in the synergistic lethality observed during polymicrobial IAI with
C. albicans and S. aureus.

Spatiotemporal Induction of the agr Quorum Sensing System In Vivo
Finally, we aimed to visualize the spread and activation of the agr quorum
sensing system during mono- and polymicrobial IAI using a luciferase reporter driven by
the staphylococcal P3 promoter. Similar to the P3-GFP reporter, the luciferase reporter
responded comparably during mono and coculture (Figure 4-7A). Mice were infected
with S. aureus(pOLux) with or without wild-type and Δ/Δzcf13 C. albicans strains.
Luminescence was captured and images taken at 4 h intervals (Figure 4-7B). The
luminescence intensity, expressed as the average of counts in regions of interest (ROI), at
each time point is shown in Figure 4-7C. Although not statistically significant, wild-type
polymicrobial infections trended higher luminescence at each time point, and
demonstrated more dispersed agr signal in the abdomen, as compared to S. aureus monoor poly-infection with Δ/Δzcf13 mutants. All mice exhibited pockets of intense
luminescence signal, which may represent high agr activity within the liver, spleen,
and/or kidneys, but this was much more pronounced in mice co-infected with wild-type
C. albicans. This qualitative approach further supports the hypothesis that C. albicans
enhances agr activity during infection in a ZCF13-dependent manner.

71

Figure 4-6. Deletion of ZCF13 in SC5314 abrogates S. aureus toxin production
and synergistic lethality.
S. aureus(pDB22) was grown alone or with C. albicans SC5314, SC Δ/Δzcf13, or SC
Δ/Δzcf13-Rev in TSB-g at 37°C with shaking. At 16 h p.i., aliquots were removed to (A)
measure fluorescence, (B) enumerate CFUs, or (C) measure ⍺-toxin levels. Experiments
were repeated in triplicate and data are expressed as mean ± SEM. (D) Mice (n = 8 per
group) were infected with 7x106 CFU SC5314, SC Δ/Δzcf13, or SC Δ/Δzcf13-Rev +
8x107 CFU S. aureus i.p. and monitored for survival for up to 5 d p.i. Experiments were
performed in duplicate and combined. Significance was assessed using a Wilcoxon log
rank test. (E) Microbial burdens at 8 h p.i. in lavage fluid and homogenized spleen and
kidneys of mice infected with SA and SC5314, SC Δ/Δzcf13, or SC Δ/Δzcf13-Rev were
enumerated by microbiological plating on selective media. Data are cumulative of two
independent repeats and expressed as the median. (F) Levels of ⍺-toxin at 8 h p.i. in
peritoneal lavage fluid and homogenized spleen and kidneys from mice infected with SA
and SC5314, SC Δ/Δzcf13, or SC Δ/Δzcf13-Rev were measured via ELISA. Data is
cumulative of two independent repeats and represented as mean ± SEM. Significance was
determined using a one-way ANOVA and Dunnett’s posttest (⍺-toxin), Mann-Whitney
test (CFU), and Wilcoxon log rank test (survival). *, P < 0.05; **, P < 0.01; ***, P <
0.001.
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Figure 4-7. Spatiotemporal agr activation during mono- and polymicrobial
infection with WT and ∆/∆zcf13.
(A) Luminescence was measured at 16 h p.i. in mono- and polymicrobial cultures of S.
aureus(pOLux) with or without C. albicans SC5314, SC Δ/Δzcf13, TF WT, or TF
Δ/Δzcf13 grown in TSB-g at 37°C with shaking. Data is cumulative of three independent
experiments and expressed as mean ± SEM. Significance was determined using a oneway ANOVA and Dunnett’s posttest. *, P < 0.05; **, P < 0.01. (B) Mice were infected
with S. aureus(pOLux) ± C. albicans SC5314, SC Δ/Δzcf13, TF WT, or TF
Δ/Δzcf13.Images were taken every 4 h p.i. using Xenogen IVIS Spectrum. Images are
uniformly scaled. (C) Luminescence values were quantified within regions of interest and
plotted as mean ± SEM. Significance was assessed using a one-way ANOVA and
Dunnett’s posttest. Ns, non-significant.
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Conclusions
Although microbes naturally exist in mixed populations, the interactions
occurring between such organisms are understudied and poorly understood partially due
to their often highly complex and multi-factorial nature. Our lab has focused on
delineating the mechanisms of interaction between C. albicans and S. aureus during
polymicrobial growth and infection. Early studies by Carlson revealed a lethal synergism
between these pathogens during polymicrobial IAI (59, 71). We previously identified the
cytolytic exotoxin, ⍺-toxin, as the staphylococcal effector of virulence, as co-infection of
an ⍺-toxin-null mutant (Δhla) with C. albicans was nonlethal and protection could be
achieved by targeting it with a monoclonal antibody (65). ⍺-toxin is a multifactorial toxin
that, in addition to its cytolytic activity, is able to stimulate a pro-inflammatory response
and disrupt platelet function. During S. aureus-induced sepsis, Surewaard et al. found
significant platelet aggregations in the livers of infected mice that were absent when an
H35L mutant ⍺-toxin was used or when mice were passively immunized with an anti-⍺toxin antibody, MEDI4893* (142). Circulating platelets were decreased, indicating the
induction of thrombocytopenia due to ⍺-toxin. Additionally, the liver-associated enzyme
ALT was increased during infection and was correlated with focal necrotic lesions in this
organ (142). A related study by Powers et al. demonstrated that ⍺-toxin alters platelet
activation as well as promotes platelet-neutrophil aggregates, which contributes to
damage to lung and liver tissue (58). Consistent with these findings, we also observed
significantly increased levels of biomarkers of kidney and liver damage during coinfection and these correlated with increased ⍺-toxin during co-infection (Figure 4-2).
While this relationship is not definitively causative, it is likely that organ damage due to
⍺-toxin is a major contributor to lethality during murine IAI. It is possible that ⍺-toxin is
disrupting the host coagulation cascade, leading to decreased circulating platelets and the
formation of platelet aggregates within the organs, consistent with multi-organ failure
seen in severe sepsis (167). However, future studies must be conducted to answer this
question.
Our lab has demonstrated that C. albicans enhances ⍺-toxin production in vitro
and in vivo (65, 122). However, the mechanism of this inter-kingdom interaction was
unclear. In order to identify and characterize the candidal factors involved in S. aureus
agr activation, we screened a collection of C. albicans transcription factor deletion
mutants. Several diverse transcriptional regulators displayed an inability to augment S.
aureus agr activity and ⍺-toxin production in vitro (Table 4-3). Three mutants (Δ/Δbas1,
Δ/Δleu3, and Δ/Δmsn4) had significant growth defects, which potentially explains the
lack of enhancement of agr activity seen in polymicrobial cultures. In fact, Δ/Δbas1 is a
known adenine auxotroph, as it mainly functions to regulate purine biosynthesis genes,
suggesting that adenine is limited in this media. GRF10 also plays a role in purine
biosynthesis and mutants have been shown to have diminished growth in media lacking
adenine, but this phenotype is not as severe as with BAS1 deletion (157).
An interesting finding from the transcription factor mutant screen is the
identification of three mutants that have defects in alkalinization during growth with S.
aureus. These transcription factors, SFL1, GRF10, and ISW2, have not previously been
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shown to play a role in pH modulation (127). However, ISW2 has been proposed to
interact with alkaline pH-response regulators during chlamydospore formation (166).
Alkalinization and morphogenesis are interconnected processes, perhaps most relevant in
macrophage phagosomes. C. albicans has evolved a way to counteract the acidic
phagolysosome by releasing ammonia produced primarily through the breakdown of
amino acids (124, 127). This neutralization permits transition from yeast to hyphae,
allowing for escape from the macrophage. While alkalinization plays a clear role in
driving staphylococcal ⍺-toxin induction in vitro, its role in vivo has not been validated,
partially due to the buffered and slightly alkaline environment of the peritoneal cavity
(68). Thus, it is difficult to determine whether partial loss of synergism in the Δ/Δsfl1
strain is due to its alkalinization defect or another uncharacterized phenotype.
Previous studies from our lab determined that morphology/morphogenesis are not
drivers of enhanced lethality during polymicrobial IAI with C. albicans and S. aureus, as
hypha-defective and constitutively filamentous strains induce the same mortality as wildtype C. albicans (66, 67). C. albicans does not form hyphae during growth in TSB-g, the
media used in our in vitro assays, supporting this finding. However, three known
regulators of hypha formation, GRF10, TEC1, and BAS1, seemed to be involved in
enhancing S. aureus quorum sensing in vitro, as mutants were unable to augment agr
activity. Other canonical inducers of filamentation, such as EFG1, CPH1, and TUP1, did
not display defects, which may indicate alternative functions of GRF10, TEC1, and BAS1
under these specific culture conditions.
Only one transcription factor mutant (TF #089, orf19.1496) displayed enhanced
agr augmentation, over 3-fold compared to S. aureus alone (Figure 4-4A, green dot).
This transcription factor is uncharacterized, but its expression may be repressed by the
iron-responsive Cap2-HAP complex (168). Though we did not further evaluate the
contribution of this transcriptional regulator in the augmentation of S. aureus agr activity
in this study, we hypothesize that polymicrobial IAI infection with this strain may be
hypervirulent, although this may be difficult to distinguish given the robust and rapid
lethality observed during wild-type co-infection.
We identified one transcription factor mutant that did not induce synergistic
lethality (TF #006, orf19.2646, ZCF13). ZCF13 is a predicted zinc-cluster transcription
factor that is similar but not truly orthologous to the HAP1 (Heme Activator Protein)
transcription factor in S. cerevisiae, which is involved in regulation of genes in response
to heme and oxygen (169, 170). While the function of ZCF13 is unknown, null mutants
have been used in various phenotypic profiling experiments. These data can help
eliminate potential functions of this regulator, although there are contradictory reports.
For example, the initial screen of the library mutants in 55 different conditions did not
detect any phenotypic abnormalities with this specific mutant. It exhibited no growth or
morphological defects on a range of medias (YEPD, synthetic defined + L-arginine and
L-leucine, minimal media) at a range of temperatures (16, 30, 37, 42 °C) and had no
observed sensitivities to antifungal drugs (fluconazole, fluphenazine, 5-fluorocytosine) or
stressors (copper, zinc, caffeine, sodium dodecyl sulfate, hydrogen peroxide, etc.) (143).
Conversely, in another study, using a separately constructed Δ/Δzcf13 mutant, it was
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found to be susceptible to increased temperature (42 °C), exhibited increased agar
invasion, and demonstrated increased colony wrinkling (155). It is possible that the
parental strain in which these separate mutants were constructed could contribute to the
different phenotypes reported. However, neither Δ/Δzcf13 mutant showed altered growth
or morphological differences in our hands (Figure 4-8).
Additionally, transcriptomic analyses under different conditions (hyphaeinducing, acidic and basic pH, high and low oxidative stress, nitrosative stress, and cell
wall damaging conditions) have not shown any significant changes in ZCF13 expression
(171-173). The expression was also unaltered in tissue culture with primary human
umbilical vein endothelial cells (HUVECs) or immortalized oral epithelial cells
(OKF6/TERT-2) (174). However, ZCF13 expression was decreased 3-fold when RBF1
was knocked out (175). RBF1 (RPG-box-binding factor 1) is a transcription factor that is
associated with mitochondrial and peroxisomal metabolism, as well as being a negative
regulator of morphogenesis (175). Thus, it is intriguing to speculate that a Δ/Δrbf1
mutant may also be hypovirulent during co-infection. As peroxisomal metabolism is
integral to fatty acid β-oxidation and the glyoxylic shunt, it will be important to
determine if these metabolic pathways are integral to C. albicans pathogenesis in the
peritoneal space. However, based on these cumulative results, Zcf13p does not appear to
be responsive to growth conditions or involved in the responses to diverse stress. Using a
combination of transcriptomic sequencing under mono and polymicrobial conditions and
tagging of Zcf13p with a C-terminal protein tag and chromatin immunoprecipitation
sequencing (ChIP-seq) approaches may reveal regulatory function of this neglected
transcription factor.
Collectively, data in this manuscript identify Zcf13p, an uncharacterized C.
albicans transcription factor, as a key regulator of trans-kingdom virulence and further
highlights the complexity of clinically relevant fungal-bacterial interactions in vivo.
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Figure 4-8. No differences in hyphal formation observed between wild-type and
Δ/Δzcf13 strains.
Cells from overnight cultures of C. albicans SC5314, SC Δ/Δzcf13, TF WT, or TF
Δ/Δzcf13 in YPD were washed and diluted into YNB and allowed to grow for 24 h at
37°C with shaking. Aliquots were removed and observed by microscopy. Images are
representative of at least two independent repeats. Scale bar represents 50 µm.
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CHAPTER 5.

DISCUSSION AND FUTURE DIRECTIONS

Candida albicans is a polymorphic, opportunistic fungal pathogen that is a major
cause of fungal infections. Staphylococcus aureus is a pervasive bacterial pathogen
capable of causing many different types of disease. While these organisms can cause
significant morbidity and mortality on their own, they are also co-isolated from both
biotic and abiotic surfaces on or within the human host. Although much research has
focused on these microbes individually, their interaction in the context of disease is not as
well understood. Early studies by Carlson described a mouse model of polymicrobial
intra-abdominal infection (IAI) that revealed a synergism between C. albicans and S.
aureus, which led to enhanced lethality compared to non-lethal monomicrobial infection
(59). Despite years of study, this interaction has not been fully elucidated. Therefore, the
purpose of this work was to answer several of the many remaining questions regarding
the mechanism of synergistic lethality between C. albicans and S. aureus: What are the
specific factors, both fungal and bacterial, that contribute to lethality? How does the host
respond to polymicrobial infection, and is this response a significant cause of morbidity
and mortality? What exactly is driving lethality: microbial growth and dissemination,
organ damage, sepsis, hyperinflammatory responses? How can we prevent, detect, and
effectively treat these types of infections?
In Chapter 2, we investigated the staphylococcal factors involved in
polymicrobial IAI using genetic approaches, qualitative and quantitative functional
assays, and a murine model of C. albicans-S. aureus infection. We found enhanced
hemolysis during coculture that is both agr- and ⍺-toxin-dependent, as an hla-null mutant
was unable to induce hemolysis in vitro and mortality during polymicrobial infection.
Importantly, survival was greatly enhanced when mice were passively immunized with
an anti-⍺-toxin-antibody MEDI4893* prior to coinfection with C. albicans and S. aureus.
These data indicate the main staphylococcal effector of synergistic lethality is ⍺-toxin
and its production is significantly increased in the presence of C. albicans.
The strain used in this work (JE2) is a USA300 isolate which exhibits high ⍺toxin expression (176). Previous studies using this model have used different S. aureus
isolates that have vastly different toxin profiles. Carlson investigated toxic shock
syndrome (TSS)-associated strains that were positive for toxic shock toxin (TST) and
non-TSS-disease-associated strains (unknown toxin profile) during polymicrobial
infection. She found that S. aureus strains that produced TST induced mortality starting
at 35 h p.i. whereas the other non-TST strains led to 100% mortality by 15 h p.i. (71).
This demonstrates that synergistic lethality is driven by S. aureus toxin but the
type/activity of the toxin produced dictates the kinetics of infection. While these findings
were undoubtedly important, the lack of isogenic strain pairs harboring toxin gene
deletions was a major limitation to identifying the precise mechanism(s) driving
synergism. In support of this, later work by Carlson suggested that δ-toxin was the main
driver of lethality during co-infection. Another group used strain NRS383 (USA200) in
the mouse model of IAI, which is positive for TST and δ-toxin but not ⍺-toxin.
Coinfection with this strain and C. albicans led to approximately 60% mortality by 2 d
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p.i. (62). While toxin levels during in vitro or in vivo growth with this strain have not
been evaluated, it is likely that they would be elevated during growth with C. albicans.
Despite differences in toxins, the in vivo infectious synergism is generally preserved with
different S. aureus strains and C. albicans. However, ⍺-toxin is not the only toxin
controlled by the agr system; others, including δ-toxin and the PSMs, are also agrregulated. Interestingly, S. epidermidis (a close relative of S. aureus) also utilizes a
similar agr system and its δ-toxin demonstrates bacteriostatic effects on Group A
streptococci, presumably conferring a selective advantage over other endogenous
microbiota during skin colonization (177). Consequently, it is possible that additional
toxins have growth inhibitory effects on C. albicans. As organisms that both largely
asymptomatically colonize the human host, it would not be particularly advantageous to
elicit such robust virulence and subsequent lethality. Thus, it is somewhat perplexing as
to why C. albicans seemingly augments S. aureus agr signaling. It is conceivable that ⍺toxin could have an antagonistic effect on C. albicans, thereby allowing for a competitive
advantage during co-culture. Preliminary studies to address this in our laboratory using
purified ⍺-toxin neither inhibited C. albicans growth nor led to the uptake of propidium
iodide to indicate fungal damage (unpublished data). Similarly, co-culture biofilm
experiments using the Live/Dead staining system and fluorescence microscopy have
revealed no apparent damage to hyphal cells. However, agr activity was not specifically
addressed in these experiments, necessitating further interrogation of this hypothesis (47).
Peters et al. identified key changes in the immune response during polymicrobial
versus monomicrobial IAI, with increases in proinflammatory cytokines and neutrophil
recruitment. In order to determine whether the immune response contributes to morbidity
and mortality, mice were treated with indomethacin prior to and during infection.
Indomethacin is a nonsteroidal anti-inflammatory drug (NSAID) that nonselectively
inhibits cyclooxygenase enzymes (COX-1, COX-2) that produce inflammatory
prostaglandins from arachidonic acid, thereby reducing inflammation (178). Mice given
the drug experienced significantly less morbidity as compared to vehicle-treated controls.
Importantly, microbial burden in the kidneys and spleen was unaltered, suggesting that
exacerbated immune responses may be driving lethality (62). Further experiments
determined that the production of the prostaglandin PGE2 was increased during
polymicrobial infection and indomethacin treatment abrogated this effect (62). PGE2 can
be induced by ⍺-toxin, is highly immunomodulatory, and induces production of proinflammatory cytokines (e.g. IL-6, KC, G-CSF, MIP-1⍺), which may be to the detriment
of the host when their production is uncontrolled. (62, 179). We measured PGE2 levels
during mono- and polymicrobial IAI and found they were significantly increased in the
latter. Although we did not specifically test this, we hypothesize that treatment with
indomethacin would also have a protective effect in our model. However, because the
USA300 strain is able to produce significantly more toxin than a USA200 strain,
indomethacin might not be as protective (62). Generally, COX inhibitors have not proven
clinically useful against human sepsis, yet more fine-tuned targeting of individual
prostaglandin receptors (EPs) has not been evaluated clinically (180). In support of this,
treatment with EP1 and EP3 inhibitors have led to marked improvement of mice
intraperitoneally challenged with C. albicans and S. aureus and may be a viable
therapeutic strategy to limit mortality (87).
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While it is clear that inflammation and PGE2 signaling partially drive lethal
outcome, ⍺-toxin has other effector functions beside membrane damage, lysis, and
eicosanoid stimulation. It can activate signaling through its high-affinity host receptor, a
disintegrin and metalloprotease 10 (ADAM10), which ultimately leads to disruption of
tight junctions and tissue desquamation on endothelial and epithelial cells (181). ⍺-toxin
has also recently been shown to activate platelet aggregation and dysregulate the
hemostatic system, resulting in excessive clotting and liver injury due to exacerbated
thrombosis (142). Interestingly, the MEDI4893* antibody that was protective against
lethal challenge during polymicrobial IAI, also prevents such thrombotic events in the
liver. Thus, it is conceivable that dysregulated hemostasis mediated by elevated levels of
⍺-toxin, followed by subsequent organ failure (defining features of sepsis and
disseminated intravascular coagulation (DIC)) contribute to the synergistic mortality
observed during polymicrobial IAI with C. albicans and S. aureus (182). Sepsis is a
complex disease state in which the dysregulation of the host immune response and
disruption of hemostasis (ranging from thrombocytopenia to DIC) leads to organ
dysfunction, septic shock, and ultimately death if not diagnosed and adequately treated
(183). Therefore, modulation of the clotting cascade may confer some level of protection
during co-infection. In fact, a recent study demonstrated that the use of aspirin could
prevent intravascular coagulation during S. aureus-induced sepsis in mice (184). Aspirin
is another NSAID that irreversibly inhibits COX-1, mediates the activity of COX-2, and
has antithrombotic properties (185). At a low dose in humans (~81 mg) it irreversibly
inhibits platelet aggregation, thus making it a common treatment to prevent heart attacks
caused by blood clots (185). Treatment with aspirin may have greater efficacy than
indomethacin in preventing morbidity and mortality in our model, as it targets two
potential host effectors contributing to lethality. Additionally, combining aspirin and
MEDI4893* could synergistically enhance survival during polymicrobial IAI.
In Chapter 4 we correlated ⍺-toxin with organ damage biomarkers in the serum,
specifically those indicating liver and kidney damage. Previous studies of staphylococcal
sepsis found that ⍺-toxin is directly responsible for platelet aggregation and liver injury,
assessed through measuring circulating platelet levels, serum ALT, and necrotic lesions
within the liver and kidneys (142). Although the liver was not analyzed for microbial
burden or ⍺-toxin production in our work, it is very likely that ⍺-toxin levels are elevated
during polymicrobial IAI in this target organ as well. Based on this collective data, we
hypothesize that the host succumbs to infection due to the multifactorial effects of ⍺toxin: cellular and tissue damage, exaggerated platelet aggregation, and hyperactive
immune responses.
In Chapter 3 we aimed to identify the candidal factor(s) involved in enhancing S.
aureus toxin production. We first tested the hypothesis that a C. albicans effector directly
interacts with the agr system via recognition by AgrC, but experimentally determined
this was not a likely mechanism. Based on prior reports that the agr system is responsive
to pH, we hypothesized that C. albicans modulates the pH during co-culture to optimum
levels. Indeed, we found that C. albicans alkalinizes the media and this correlated with
higher agr activity. An alkalinization-deficient C. albicans mutant, stp2Δ/Δ, was unable
to raise the pH during in vitro growth with S. aureus and was also unable to enhance ⍺82

toxin levels. In support of this, different Candida species displayed disparate
alkalinization potentials, with those able to raise the pH also inducing higher ⍺-toxin
production (C. albicans, C. krusei, C. tropicalis). Species with defects in alkalinization
were unable to augment toxin levels (C. dubliniensis, C. glabrata, C. parapsilosis). This
data strikingly matches in vivo mortality data using the same Candida species in the
murine polymicrobial IAI model (67). Although C. albicans-mediated alkalinization
plays a role in synergism with S. aureus in vitro, this unfortunately did not translate in
vivo, as the stp2Δ/Δ strain was lethal similar to wild-type co-infection (Figure 4-1). It’s
possible that other mechanisms of pH modulation exist, or that pH in combination with
other factors, such as metabolic byproducts, are also involved. Biological pH is strictly
maintained within different anatomical sites and it is entirely possible that C. albicans
cannot cause large, global shifts. Perhaps this effect is only seen in the microenvironment
when C. albicans and S. aureus are in close proximity, as commonly observed in
polymicrobial biofilms. These two organisms have been shown to form biofilms together
and that gene expression is altered during this growth modality (47). However, S. aureus
⍺-toxin production or pH changes have not been directly examined during biofilm
growth. Experiments to determine if pH drives agr activity could be performed using the
stp2Δ/Δ strain and wild-type C. albicans to answer this question in a potentially more
relevant system.
Given the challenges faced with interrogating the impact of pH on driving
lethality in vivo, in Chapter 4 we undertook an unbiased screening approach to identify
other candidal factors that influence S. aureus agr activity and ⍺-toxin production. We
identified several transcription factors that appeared to be necessary for this specific
interaction: SFL1, ZCF13, GRF10, TEC1, ISW2, and BCR1. Despite deficiencies seen in
vitro, only one of these mutants failed to synergize with S. aureus in vivo: Δ/Δzcf13. This
transcription factor is uncharacterized and its function unknown. Our lab is currently
performing transcriptomic and metabolomic analyses to uncover the role that ZCF13
plays during the interaction between C. albicans and S. aureus. We also plan to utilize
chromatin immunoprecipitation sequencing (ChIP-seq) to identify DNA-binding sites of
ZCF13, which may illuminate genes that are regulated by this transcription factor. It is
possible that expression of ZCF13 is altered in the presence of S. aureus or other bacteria
and is involved in inter-microbial interactions. Other possible functions could be related
to production of metabolic byproducts that impact S. aureus quorum sensing or
protection from immune cells during infection. S. aureus virulence has been shown to be
altered in response to pyruvate, an important molecule in cellular metabolism (186).
Perhaps Zcf13p regulates genes that, under certain conditions, alter pyruvate production
or secretion. Since ZCF13 in C. albicans is orthologous in sequence to HAP1 in S.
cerevisiae, it may be involved in iron-responsive pathways. Iron is an essential element
but is tightly sequestered in the human body, leading to microbes evolving mechanisms
for iron acquisition (187). It’s possible that C. albicans and S. aureus compete for
acquisition within the host, thereby leading to enhancement of virulence mechanisms.
Future studies investigating the survival of Δ/Δzcf13 mutants within macrophages or
metabolic profiling of mutants in the presence of S. aureus could answer these questions.
Putative ZCF13 orthologs exist in the various Candida species utilized in Chapter 3
(CPAR2_501580 in C. parapsilosis; Cd36_53120 in C. dubliniensis; CAGL0B03421g in
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C. glabrata; CTRG_02695 in C. tropicalis) and potential functional differences may
correlate with the ability to cause lethal synergism (188, 189).
In conclusion, this work identifies ⍺-toxin as the staphylococcal effector, and
proposes ZCF13 as a candidal factor, in driving synergistic lethality in polymicrobial
intra-abdominal infection. Future studies will continue to unravel the complex
mechanism of interaction between C. albicans and S. aureus, ultimately leading to new
prophylactic or therapeutic strategies to better manage devastating fungal-bacterial intraabdominal infection.
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